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Community pharmacy practice in Ontario is undergoing a paradigm shift, moving from a 
product-centered to a patient-centered orientation. As a result of increased demands on Ontario’s 
healthcare system, the provincial government enacted legislation that expanded the scope of 
practice for pharmacists, authorizing them to deliver clinical services in a pharmacy setting. The 
provincial government also introduced a regulated pharmacy support staff role, the Pharmacy 
Technician (PT) to assist pharmacists in managing the resulting higher demands on them. This 
Organizational Improvement Plan (OIP) seeks to address performance concerns in an 
organization that operates two community pharmacies that arose as a result of these legislative 
changes. The OIP advocates for a comprehensive approach to organizational change that focuses 
on both external and internal organizational factors that contributed to the problem of practice. 
The OIP champions a leadership approach that emphasizes both structural and relational 
elements of leadership. Through a patient education initiative, the OIP attempts to counter 
misperceptions that patients may have regarding the roles that different pharmacy team members 
play. The OIP also proposes redesigning the pharmacy workflow process in order to better 
integrate PTs, enable pharmacists to improve the delivery of clinical services, and achieve 
efficiencies within the pharmacy. These changes are introduced in the OIP through a detailed 
leadership-driven implementation plan which is complemented by a change process monitoring 
and evaluation strategy and a change communication plan. While this OIP was tailored 
specifically to the needs of one organization, this problem of practice is not unique to it. As such, 
the analysis that was performed, the proposed leadership approach, and the change plan that was 
devised can provide important insights to other community pharmacies within Ontario, across 
Canada, as well as in other countries where similar legislation has been introduced. 
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Community pharmacy practice in Ontario has undergone major changes over the last two 
decades (Gregory & Austin, 2007). For the longest time, a pharmacist’s role was largely limited 
to dispensing drugs prescribed by physicians to customers (Remington, 2006), which generated a 
business mindset in pharmacists and contributed to a public perception of pharmacists as profit-
driven purveyors of products as opposed to healthcare professionals (Perepelkin & Dobson, 
2009). Increasing demands on the healthcare system, however, led the provincial government to 
revisit the role that pharmacists play in the delivery of services and the management of disease in 
an effort to alleviate some of the pressure on the system. As a result, in 2009, Bill 179 came into 
effect and expanded the scope of practice for pharmacists, allowing them to deliver clinical 
services in community pharmacy settings, such as renewing prescriptions, administering certain 
drugs by injection, and managing chronic diseases such as hypertension (Ontario College of 
Pharmacists [OCP] 2012, 2014). This legislative change precipitated several outcomes in 
community pharmacies, chief of which was an increased demand and higher workloads for 
pharmacists, who in addition to being responsible for the drug dispensing role, were now also 
required to deliver clinical services to patients. As a result, the provincial government introduced 
a new regulated pharmacy support staff role, the Pharmacy Technician (PT) in order to assist 
pharmacists in managing these new demands (National Association of Pharmacy Regulatory 
Authorities, 2014).  
This Organizational Improvement Plan (OIP) is concerned with the consequences that 
this shift in community pharmacy practice from a product-centered to a patient-centered model 
has had (Babb & Babb, 2003). The OIP focuses on my organization, which is a pharmacy 
services company that owns and operates two franchised retail pharmacies. Since the expansion 
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of the scope of practice for pharmacists and the introduction of PTs, my organization has 
experienced several concerning changes in performance such as increased dispensing error rates, 
lower employee and customer satisfaction, and increased safety incidents, all of which are key 
symptoms of my problem of practice. In order to better understand the context of the problem 
practice, the OIP provides an extensive review of the literature and a thorough description of the 
evolution of pharmacy practice in Ontario (Gregory & Austin, 2017; Lynas, 2011). In light of 
this context, the OIP advocates for a leadership style that is adapted from the two prevalent 
forms of exercised leadership in the organization, transactional leadership and Leader-Member 
Exchange (LMX). The OIP further contends that a Structured Relational Leadership style is 
required in order to address both the structural and behavioural dimensions of the problem of 
practice. These dimensions were also identified by an in-depth organizational analysis using 
Nadler & Tushman’s (1980) congruence model, as were other related areas of misalignment 
within the organization. 
To address the problem of practice, the OIP adopts a comprehensive approach to change, 
and proposes a change plan based on two suggested solutions. The first is a patient education 
initiative that aims to counter patient misperceptions about pharmacy support staff roles as well 
as improve the delivery of clinical services. The second solution involves redesigning the 
pharmacy workflow (the process by which prescriptions are filled in the pharmacy) in order to 
better integrate PTs in pharmacy operations, as well as improve efficiency. To that end, the OIP 
presents a detailed implementation plan for each solution, outlining the steps and the resources 
that are required. The OIP employs Kotter’s (2012) eight-step organizational change framework 
as the foundation for the plan’s implementation. In order to ensure that change unfolds smoothly, 
and that progress and the outcomes of change are accurately captured, the OIP also provides an 
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extensive monitoring and evaluation strategy. By monitoring progress and evaluating the 
outcomes of change, leaders in the organization can be agile and adjust the change plan as 
needed. Communication is a critical component of any organizational change initiative 
(Armenakis & Harris, 2002; Kotter, 2012). Accordingly, a thorough communication strategy and 
plan are put forth in the OIP to ensure that all the affected stakeholders are consulted and that 
they remain well informed and engaged throughout the change process.  
As with any change plan, the OIP has several limitations, the most critical being that two 
solutions (change efforts) will be implemented simultaneously. This holistic approach, while 
necessary, could potentially over-extend the organization’s resources and leadership, and as 
such, careful monitoring and constant evaluation of progress and outcomes are essential. The 
OIP’s problem of practice is complex and unraveling its roots through the organizational analysis 
revealed its multi-dimensionality and that it manifests at all levels of the organization. A key 
challenge for community pharmacy practice now and in the future relates to its dual existence in 
the private for-profit sector and in the public healthcare domain. Despite the comprehensive 
nature of the changes promoted in this OIP, it is unlikely that they will resolve this inherent 
tension and the conflicting demands on my, and other organizations operating in this field. Along 
the same lines, the problem of practice has significant ethical considerations which are touched 
upon in the OIP, but that extend beyond my organization. It is therefore essential that the 
discourse regarding the role of pharmacists as healthcare providers continues, especially in light 
of the increasing demands on the entire healthcare system. The implications of simply 
maintaining the status quo are far too grave for scholars and practitioners to ignore, given the 
ramifications on patients’ wellbeing, health, and safety. 
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Glossary of Terms 
 
Expanded scope of practice of pharmacists: The ability for pharmacists in the province of 
Ontario to provide healthcare services and perform procedures such as the delivery of drugs via 
injection or inhalation, as outlined in Bill 179. 
MedsCheck: A government-funded program that allows pharmacists to conduct comprehensive 
reviews of patients’ medication and providing pharmaceutical treatment opinions to physicians 
as required. 
Pharmacy Assistant: Pharmacy support staff whose role is limited to clerical and retail duties 
(e.g., prescription entry, cashing out patients). The Pharmacy Assistant role is unregulated.  
Pharmacy Technician: Pharmacy support staff who are trained and certified to perform all 
technical aspects of the prescription filling function including the gathering of patient 
information and product preparation, distribution and inventory control. The Pharmacy 
Technician role is regulated by provincial governing bodies.  
Pharmacy Workflow: The standardized process for filling prescriptions and delivering services. 
Structured Relational Leadership: A leadership style that combines structural elements from 
Transactional Leadership such as task assignment and delegation with relational elements from 
Leader-Member Exchange (LMX) such as engagement, communication and trust. 
Wage-cost-per-script (WCPS): Profitability metric based on a calculation that considers the 
average labour costs involved in filling a single prescription. 
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Chapter 1: Introduction and Problem 
This Organizational Improvement Plan (OIP) examines the role of leadership and 
organizational change in mitigating the impact of regulatory and legislative changes on 
community pharmacy practice in Ontario, Canada. While several theoretical frameworks and 
models are introduced and utilized throughout the OIP, both as framing and analytical tools that 
shape the OIP’s arguments, recommendations and conclusions, at a macro-level the OIP is also 
interrogated and viewed through a neoliberal lens. I chose this particular lens for two main 
reasons the first of which is that neoliberalism aligns with my personal worldview and by 
extension my leadership and decision-making. Second, a neoliberal understanding of the unique 
organizational context within which this OIP is embedded allows for critical insights and an 
appreciation of the various forces that have shaped the problem of practice as well as informed 
the organizational analysis and the proposed change plan. The OIP is divided into three chapters, 
the first of which provides an introduction of the organizational context and the problem of 
practice. Chapter one also frames the problem of practice by examining the multilevel factors 
that shape it, followed by introducing a vision for organizational change. The chapter concludes 
by examining the organization’s readiness for change.  
Organizational Context and History 
My organization is a pharmacy services company (Organization X) that currently owns 
and operates two franchised retail community pharmacies under the banner of ParentCorp in 
Ontario.  Founded in the mid 1900s, ParentCorp is comprised of a vast network of over 1,000 
pharmacies across Canada (ParentCorp, 2018a). While pharmacies are independently owned and 
operated, similar to other retail pharmacy chains in the country, ParentCorp provides store 
owners with operational support through its vast logistical network and resources. Being a 
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privately-owned for-profit organization providing public healthcare services and products 
presents unique challenges in my operational environment, which will be explored in depth in 
the organizational analysis section of the OIP in chapter two. There are also additional 
challenges that have been precipitated by recent fundamental changes to the practice of 
pharmacy in Ontario which I explore in the following section. 
The Evolution of Pharmacy Practice – from Product to Patient-centered Care 
Pharmacy practice in Ontario, across Canada (Gregory & Austin, 2017; Lynas, 2011), 
and in several western countries (Koehler & Brown, 2017) is undergoing a major paradigm shift 
(Nasra, 2018a). Increased demands on the healthcare system have led governing bodies to re-
examine the role that community pharmacies play in the delivery of essential services to the 
public, and to enact significant changes aimed at confronting the core challenges facing this 
sector.  
A pharmacist’s role has traditionally been associated with dispensing medications 
prescribed by physicians as well as medication management (Abramowitz, 2009; Remington, 
2006). These two functions are interdependent and complementary since pharmacists are the 
only healthcare professionals with drug dispensing authority and knowledge of the effects of 
drugs, their correct dosing, and their pharmacological appropriateness (Remington, 2006). Given 
that the majority of community pharmacy practice takes place in the private retail sector, the 
emphasis of pharmacy practice for many decades has traditionally been on dispensing 
medications as opposed to medication management (Canadian Pharmacists Association [CPhA], 
2015; Ontario College of Pharmacists [OCP], 2012). This product-centered approach engendered 
a business mindset in community pharmacies which was further enhanced by the profit-driven 
nature of the overall pharmaceutical industry. Over the last two decades increasing demands on 
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the entire healthcare system have resulted in the resurgence of medication management and the 
provision of complementary clinical services as a necessary function for pharmacists (OCP, 
2012; Ontario Pharmacists Association [OPA], 2014). Legislation and a shifting business 
landscape have also contributed to making these tasks, among others, central to pharmacy 
practice.  
The pharmacist role. Over the last decade, the Ontario Government passed regulations 
and enacted changes to the laws which govern the profession of pharmacy (Lynas, 2011; OCP, 
2012). In 2009, Bill 179 received royal assent to expand the scope of practice for pharmacists 
(OCP, 2012; OPA, 2014). Among other things, Bill 179 authorized pharmacists to perform 
several clinical functions in community pharmacies such as the renewal or adaptation of 
prescriptions, the prescription of medications for smoking cessation, the administration of 
vaccines and certain drugs by injection or inhalation, and the pharmaceutical management of 
chronic diseases such as diabetes and hypertension (OCP, 2012; OPA, 2014). 
The expanded scope of practice for pharmacists was promoted, in part, as a response to 
the increased demand for healthcare services and the scarcity of resources that plagued the entire 
public healthcare system (Guirguis, Johnson, & Emberley, 2014; Nasra, 2018a). It was also 
viewed as one way to partially offset financial losses that pharmacies were taking on because of 
additional regulations. For example, the Ontario Drug Benefit Act, introduced in 2010, reduced 
the price of generic drugs and capped the amount that the provincial government would pay 
pharmacies for dispensing both generic and brand-name drugs. Additionally, Bill 102, the 
Transparent Drug System for Patients Act, eliminated professional allowances and rebates that 
pharmacists received to cover certain patient care initiatives (Grindrod, Sanghera, Rahmaan, 
Roy, & Tritt, 2013; VanderElst, 2010). Community pharmacies had long relied on these 
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allowances to cover the gap that existed between the actual cost and the amount paid by the 
government for prescription drugs (Rosenthal, Austin, & Tsuyuki, 2012). Studies that sought to 
examine the effects of the collective changes to the operational environment of community 
pharmacies confirmed their detrimental impact on pharmacy operations and revenue (e.g., 
Rosenthal et al., 2012). 
Given these legislative changes, the expanded scope of practice for pharmacists presented 
new potential income streams as pharmacies began receiving remuneration from the provincial 
government for the delivery of clinical services (Grindrod et al., 2013). For example, as part of 
the management of medications, the Ontario Government introduced the MedsCheck program, 
which allowed pharmacies to be compensated for performing comprehensive regular reviews of 
patients’ medications and addressing any inconsistencies or concerns that arose from those 
reviews by providing pharmaceutical treatment opinions to physicians (Grindrod et al., 2013). 
Pharmacies also started receiving compensation for the delivery of vaccines and the 
administration of other drugs such as methadone for the treatment of opiate addiction (OCP, 
2012; OPA, 2014).  
These new regulatory and financial realities of pharmacy practice rapidly transformed the 
environment in which community pharmacies operated. Given that opting out of providing 
services outlined within their expanded scope was not an option, pharmacists, despite their 
extensive training, had to adapt and learn new skills as they began incorporating the delivery of 
clinical services into their daily workflows (Nasra, 2018a). While the expanded scope of 
practice’s main goal was to facilitate patient access to healthcare services, both the practitioner 
community and governing bodies have admitted that the adoption and provision of these services 
has been much slower than anticipated and not without its challenges, chief of which were the 
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significant increase in pharmacist workload and insufficient resources (Nasra, 2018a; OPA, 
2014; Silversides & Tierney, 2013). The need for more specialized support and assistance to 
manage the increased demand on pharmacists quickly became evident as a critical point of 
failure in this new operational environment and in response, the OCP formalized and introduced 
a new regulated pharmacy support staff role, the Pharmacy Technician (PT) (OCP, 2015). 
The PT role. Until 2010, pharmacy teams consisted of pharmacists and Pharmacy 
Assistants (PAs) whose role was mostly clerical (Nasra, 2018a; OCP, 2012). In contrast, a PT’s 
scope of practice encompassed managing all the “technical aspects of the prescription, the 
gathering of patient information for the pharmacist to review, product preparation, product 
distribution and inventory control” (National Association of Pharmacy Regulatory Authorities 
[NAPRA], 2014, p.3; Williams, 2014). A comparison of the pharmacist, PA and PT roles is 
presented in Table 1.  Of important note is that the introduction of the PT role was not 
accompanied by any legislative requirement to hire PTs, nor were there any efforts to formalize 
or regulate the traditional PA role (Nasra, 2018a).   
Table 1 
 
Pharmacist, Pharmacy Technician, and Pharmacy Assistant Tasks 




Enters patient and 
prescription information  
X X X 
Cashes out/ delivers 
prescriptions 
X X X 
Completes filing tasks X X X 
Completes technical tasks 
related to prescription 
filling 
X X  
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Table 1 (continued). 
Signatory authority for 
technical component of 
prescription filling and 
checking 
X X  
Overall signatory authority X   
Patient counseling X   
Clinical services (e.g., 
immunizations, 
prescription renewal) 
X   
Workflow management X   
 
As can be noted in Table 1, pharmacists are still ultimately accountable for the 
therapeutic and clinical appropriateness of all prescriptions dispensed in the pharmacy (CPhA, 
2015). Pharmacists are also able to perform all support staff tasks, and there is a significant 
overlap between pharmacist and PT tasks as they pertain to dispensing medications, which is a 
critical factor for the problem of practice that will be addressed in various sections of this OIP. 
The Organizational Context from a Neoliberal Lens 
Neoliberalism, which symbolizes a shift towards “greater marketization”, has become a 
part of the modern lexicon (Bloom, 2017; Davies, 2014a). Despite its ubiquitous use, the term 
neoliberalism, especially outside an economic context, remains relatively ambiguous which 
could be attributed to the various perspectives of the theory that currently exist (cf. Clarke, 
2008). While its origins emerged from the works of Friedrich Hayek in the 1930s and 1940s, and 
later championed by Milton Friedman in the 1970s (cf. Mirowski & Plehweh, 2009), Harvey’s 
(2005) conception of neoliberal philosophy best captures its essence and broad humanistic 
implications. “Neoliberalism is in the first instance a theory of political economic practices that 
proposes that human well-being can best be advanced by liberating individual entrepreneurial 
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freedoms and skills within an institutional framework characterized by strong private property 
rights, free markets, and free trade” (Harvey, 2005, p. 2).  
 Much of the criticism levied against neoliberalism stems from a specious utopian view 
that self-interest alone can generate societal welfare, which is often conjured up with the image 
of Adam Smith’s “invisible hand” that governs free markets and “whereby individual self-
interest produces generalized welfare” (Bloom, 2017, p.6). More recent reviews and examination 
of neoliberal theory (e.g., Davies, 2014a; Gane, 2014) however, have shifted away from this 
overly simplistic pro-market capitalist depiction, to a more complex and refined view in which 
both the individual and the state play critical roles (Amable, 2011; Davies, 2014a) and are 
enmeshed in all aspects of social life, and where fundamental social concepts such as morality 
and ethics are also considered (Bloom, 2017; Harvey, 2005). While a thorough examination of 
neoliberal philosophy is beyond the scope of this OIP, one key element that needs to be 
highlighted is the role that the state/government plays in “creating markets” (e.g., through 
privatization) and promoting standardization and self-regulation (Bloom, 2017; Davies, 2014a). 
Neoliberalism does not dictate that governments should not have any role in the functioning of 
the economy, what distinguishes neoliberalism from liberalism is the view that governments 
“have certain functions to fulfill in order to make markets function … particularly market-
enabling actions” (Biebricher, 2015, p.1). 
 Viewing the OIP’s context from a neoliberal perspective allows for a nuanced 
understanding of some of the changes that the industry has experienced. As noted, the impetus 
behind expanding the scope of practice for pharmacists and the regulation of the PT role was a 
broader systemic increased demand on the provincial healthcare system that had become 
unsustainable, inefficient and whose costs had spiralled out of control (Guirguis et al., 2014). 
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While an ideal neoliberal approach to addressing this problem would have been to privatize 
healthcare; the actions that the government has taken (i.e., expanding of the scope of practice for 
pharmacists) also represents a form of privatization of some aspects of healthcare, or 
“reinvent[ing] them in a ‘market-like’ way” which is in line with a neoliberal view (Davies, 
2014a, p. 310). By taking on non-critical medical services such as renewing prescriptions, 
managing the treatment of chronic disease, and providing vaccinations, hospital and clinic visits 
could be reduced, decreasing the overall demand on the healthcare system while rendering those 
services to patients more efficiently through community pharmacies (Bloom, 2017; Davies, 
2014b). A consequence of this expanded scope of practice, described earlier, was the increased 
demand for services in pharmacies, which meant that pharmacists, without the support of trained 
support staff to assist them, bore the brunt of this increased demand (OPA, 2014; Silverside & 
Tierney, 2013).  
Given the importance of providing standardized, effective high-quality healthcare, one 
could argue, from a neoliberal perspective, that these circumstances created the need for 
government intervention in the form of creating the regulated PT role (Bloom, 2017; Davies, 
2014b; Harvey, 2005). In line with a neoliberal view, this intervention stopped short of 
interfering with pharmacy management’s ability to direct operations as they saw fit, hence no 
legislation was imposed that mandated the hiring of PTs. Management, through careful 
consideration of the costs and benefits, could determine the appropriate number of PTs to hire in 
order to maximize efficiency and effectiveness while reducing costs. Moreover, once PTs were 
hired, management could regularly monitor performance metrics both at the organizational and 
individual level to ensure that standards and goals were being met.  
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Alternatively, a neoliberal approach could also view governmental intervention as 
interference in the operations of pharmacies, preventing them from naturally adapting to this 
increased demand and perhaps finding more innovative cost-effective and efficient solutions 
such as the automation of some tasks in the pharmacy (e.g., prescription filling). For the 
purposes of this OIP, as will be elaborated in chapters two and three, some of the 
recommendations that I put forth stem from this view that seeks to find efficiencies and 
emphasizes the neoliberal tenets of self-regulation and standardization (Davies, 2014a). 
Vision, Mission, Purpose and Goals 
ParentCorp’s mission and driving purpose revolves around supporting the needs and 
well-being of customers which is achieved by adhering to the corporate values of “care, 
ownership, respect and excellence” (ParentCorp, 2018b). While my organization has obligations 
to ParentCorp, both fiduciary and operationally, the independence afforded by the ParentCorp’s 
franchise model enables my organization to maintain its own goals and core values that extend 
beyond those of ParentCorp.  
Given that my organization is entrusted with providing healthcare services, I strongly 
believe that our responsibility is ultimately to the patient, regardless of their socioeconomic 
status or background. While for-profit, my organization also believes in the moral obligation to 
care for patients regardless of their socioeconomic status and their ability to pay. The expanded 
scope of practice for pharmacists represents an important opportunity because it enables my 
organization to care for patients using a holistic approach that goes beyond dispensing 
medications. I also strongly believe in the importance of being good citizens, and as such my 
organization is actively engaged in outreach initiatives to assist vulnerable groups in the 
communities it serves. Staff are trained to care for patients seeking substance-dependence 
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treatment, those who are HIV positive, those suffering from mental disorders as well as patients 
with terminal illness. This type of engagement with patients reflects my organization’s values 
and is centered on my belief in the noble mission of the profession of pharmacy (Nasra, 2018a). 
Organizational Structure and Established Leadership Approaches 
As per the OCP, leadership is one of the competencies that both pharmacists and PTs are 
required to demonstrate (OCP, 2012). The two most senior leadership roles in the organization 
are occupied by me, as a partner and Chief Human Resources Officer (CHRO), and by the other 
partner who is also the Chief Pharmacist. As such, the great majority of organizational-level 
leadership decisions rest with us. Given the highly regulated nature of the industry, clear lines of 
authority are necessary. The need for accountability requires my organization to be hierarchical 
in structure because leaders and management need to have the necessary oversight to ensure 
regulatory compliance. 
On a day to day basis leadership features greatly in the actual operation and functioning 
of the pharmacy and is regularly practiced by pharmacy staff. The community pharmacy context 
is relatively unique, with pharmacy operations being carried out by teams comprised of a 
pharmacist and one or more support staff members (PT or PA) who work in shifts. During a 
shift, one team is responsible for all aspects of the operation of the pharmacy, with the ultimate 
authority residing with the pharmacist who holds the ‘official’ leadership role. The pharmacist on 
duty is the sole decision-maker and is responsible for managing support staff and overseeing 
their tasks. Given the nature of the organization’s work, the two most prevalent styles of 
leadership that are exhibited are transactional leadership, and dyadic relationship-based 
leadership (i.e., Leader-Member Exchange, LMX).  
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Transactional Leadership. The highly task-oriented nature of both the pharmacist and 
support staff roles means that a typical shift revolves around the organization and performance of 
predetermined tasks. In that regard, pharmacists act as transactional leaders, setting explicit goals 
that need to be accomplished. The emphasis and ultimate objective of each pharmacy team is to 
achieve maximum efficiency while maintaining high standards of safety and service (Van Wart, 
2013; Vera & Crossan, 2004). Given the highly regulated nature of the industry, standards of 
practice, codes of conduct, and systems and processes are set out by regulatory bodies (e.g., the 
OCP in Ontario), by ParentCorp, and by my organization.  
As mentioned earlier, as franchisees, my organization has fiduciary obligations to 
ParentCorp, and as such, most of the processes and systems that are in place are focused on 
achieving efficiencies and increasing productivity. Mistakes, such as dispensing errors, are 
documented and logged systematically and audits are regularly performed by regulatory bodies. 
Employees who violate any of the set processes are reported and/or sanctioned. The regular 
performance of tasks that are repeated in every shift leads to established routines and workflows 
which are ultimately derived from basic standard operating procedures (SOPs). All the above 
factors contribute to a highly transactional environment exhibiting all the hallmarks of 
transactional leadership (Hackman & Johnson, 2013; Judge & Piccolo, 2004). 
Leader-Member-Exchange. As indicated above, during each shift, the pharmacist and 
support staff work in conjunction, with the pharmacist taking on the official leadership role and 
the support staff (PT or PA) taking on the subordinate/follower role. This relationship-based 
dynamic is built on dyadic interactions between leader and follower which exhibit several 
hallmarks of LMX leadership theory (Bauer & Erdogan, 2015; Graen & Uhl-Bien, 1995).  
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Research and internal data suggest that pharmacists exhibit a more pronounced sense of 
trust and respect for PTs than PAs (Bauer & Erdogan, 2015; Bullock, Allan, Barnes, Hodson, & 
Russ, 2016; Deluga, 1998; Nasra, 2018a; Organization X, 2016b, 2017b). This can be explained 
in part by the technical knowledge that a pharmacist and a PT share because of their education, 
and because of the ability of pharmacists to delegate some of their responsibilities to PTs. The 
beginning of the task delegation process typically involves a stage where the pharmacist mentors 
and teaches the PT as to their preferred method of doing things. Internal data, as well as research 
findings, have also revealed that pharmacists describe their relationship with PTs as being more 
collaborative than with PAs where they view their role as being more supervisory (Bradley, 
Schafheutle, Willis, & Noyce, 2013; Bullock et al., 2016; Nasra, 2018a; Organization X, 2016b, 
2017b). This differential treatment can potentially result in PAs feeling undervalued, as well as 
the creation of “in groups” and “out groups” which have been examined in LMX literature 
(Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995). In chapter two, I put forth a framework for a 
proposed leadership approach that combines critical aspects of both Transactional Leadership 
and LMX and elaborate on how emphasizing both structural and relational elements of 
leadership are fundamental to my OIP. 
Leadership Position and Lens Statement 
Leadership is complex, but it is also personal and idiosyncratic. Drenkard (2012) stated 
that “the genius of leadership lies in the manner in which leaders see and act on their own and 
their followers’ values and motivations” (p. 148). Succinctly put, my leadership philosophy is 
about empowering and engaging my employees in the pursuit of my organization’s vision and 
goals. Only by empowering followers can a leader achieve meaningful outcomes. I strongly 
believe that an effective leader is one who enables his/her followers to reach their full potential 
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and in doing so, also enables organizational success (Maxwell, 2007; Nasra, 2018a). An 
examination of the values and behaviours that drive my leadership reveals an alignment with 
some tenets of authentic and adaptive leadership theories. While the leadership approach I 
propose in this OIP is not based on these theories, as will be discussed in chapter two, there are 
key relational elements that are shared by these leadership styles, especially as they pertain to 
outcomes such as trust and engagement.  
Gardner, Avolio and Walumbwa (2005) state that “authenticity involves both owning 
one’s personal experiences … and acting in accordance with one’s true self” (pp. 344-345). 
Authenticity to me is not only about the congruence between one’s own experiences and actions. 
What is critical, I believe, is the self-awareness and introspection that authenticity requires. Kurt 
Vonnegut wrote “[w]e are what we pretend to be, so we must be careful about what we pretend 
to be” (2009, p.v). This quote resonates with me because I believe that no matter how hard we 
try to be true to ourselves in a work setting, especially as leaders, it is not always possible to be 
truly authentic all the time. As such, equally important is being mindful of who I project myself 
to be in front of my followers. Mindfulness involves “[p]aying attention on purpose, in the 
present moment” (Kabat-Zinn, 2005). As such, I believe that the more mindful and self-aware I 
am as a leader, the more likely I am to be authentic, relatable and trustworthy (Nasra, 2018a).  
I believe that leadership is situational and successful leadership needs to be adaptable and 
flexible (Nasra, 2018a). Dealing with a complex operational environment, as many organizations 
do, requires constant analysis, recalibration and agility to ensure that both the leader and the 
organization are responding to changes, threats and opportunities in a timely manner. As such, 
introspection, reflection and mindfulness also play an integral role because by constantly paying 
attention to the present situation, a leader can objectively see what is or isn’t working and adjust 
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accordingly (DeRue, 2011; Heifetz, Grashow, & Linsky, 2009). In doing so, a leader can make 
necessary changes and adjustments as needed and identify potential problems before they 
become major obstacles (Sauer & Kohls, 2011). I believe that this adaptability builds resiliency 
within the organization and contributes to success in the long term. My leadership philosophy, 
values, beliefs and assumptions reflect my current view of the world we live in; one where 
complexity and rapid change are becoming the norm. Complexity and change require that leaders 
adapt, accept, and learn from failure and develop a better awareness of the people they work with 
and the environment the organization operates in. The change plan that I detail in chapter three 
highlights this critical need for evaluation and recalibration through careful monitoring of how 
change is unfolding in the organization.  
As indicated at the beginning of this chapter, the approach that has informed my OIP is 
rooted in a neoliberal perspective that emphasizes efficiency, self-regulation, and standardization 
(Bloom, 2017; Davies, 2014b). These constructs are inherently tied to structural elements and 
conditions both within the organization and its operational environment. To best understand the 
variables that influence the problem of practice, it is therefore important both from an analytical 
and a theoretical perspective to frame the problem of practice by focusing on the structural 
dynamics and forces within the organization. To that end, after summarizing and stating the 
problem of practice below, I make use of Bolman and Deal’s (2013) organizational analysis 
framework, more specifically the structural frame as a lens through which critical insights about 
my organization can be gleaned and understood.  
Leadership Problem of Practice 
As CHRO and partner in Organization X, a pharmacy services company that currently 
owns and operates two community retail pharmacies in Ontario, it is my responsibility to ensure 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 15  
 
 
that our pharmacies properly adapt to the aforementioned changes in the industry (Nasra, 2018a). 
Since the introduction of PTs and the expansion of the scope of practice for pharmacists, my 
organization has observed several concerning outcomes such as: higher rates of dispensing errors 
and incidents impacting patient safety, lower customer satisfaction and decreased employee 
engagement (Organization X, 2016a, 2016b, 2017a, 2017b). As such, my problem of practice 
seeks to address the negative impact on organizational performance and customer service 
resulting from recent legislative changes that have expanded pharmacists’ scope of practice 
(Nasra, 2018a).  
Framing the Problem of Practice 
The historical evolution of the problem of practice, as outlined earlier, reveals that 
pharmacy practice in Ontario, across Canada (Gregory & Austin, 2017; Lynas, 2011), and in 
other western countries (e.g., Koehler & Brown, 2017) is undergoing a major paradigm shift. In 
this section, using Bolman and Deal’s (2013) organizational analysis framework, specifically the 
structural frame, I examine the multilevel factors that influence and shape the problem of 
practice. I follow this with a brief overview of the recent literature on the topic. Both these 
efforts involve an examination of the political, economic, social and technological (PEST) 
factors that are relevant to the problem of practice, which are summarized at the end of this 
section in Table 2.  
Bolman and Deal’s (2013) Organizational Analysis Framework  
In their seminal work, Bolman and Deal (2013) synthesized organizational theory’s major 
schools of thought into their four-frame approach for analysing organizations. Broadly speaking, 
a frame is “a mental model; a set of ideas and assumptions” through which individuals view and 
make sense of organizations and situations (Bolman & Deal, 2013, p. 11). As per Bolman and 
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Deal (1991), frames are also “preconditioned lenses and filters” that enable organizational 
leaders to process information about their organizations, further enhancing their understanding. 
Bolman and Deal (2013) put forth four such frames or lenses through which organizations could 
be viewed: structural, human resources, political, and symbolic.  
While each of the four frames provides unique insights and understanding of the 
organizational dynamics and processes underlying my problem of practice, the analysis below is 
limited to the structural frame given the high degree of alignment between its assumptions, 
imperatives and dilemmas and my organization’s current state (Bolman & Deal, 2013; Nasra, 
2018a), as well as its complementarity with the neoliberal perspective (Davies, 2014b). 
The structural frame. As a healthcare provider, my organization is part of a highly 
regulated industry where an emphasis on standards of practice is part of organizational reality. In 
addition to the oversight through standards developed by governing bodies, such as the OCP and 
the Ontario Ministry of Health and Long-Term Care, additional levels of oversight are enabled 
through both ParentCorp’s policies as well as internal guidelines (Nasra, 2018a; ParentCorp, 
2018b). This type of control is a key feature of the structural frame (Bolman & Deal, 2013).  
The structural frame and neoliberal perspectives emphasize rationality and efficiency 
(Bolman & Deal, 2013; Brown, 2003; Davies, 2014b; Harvey, 2005; Lemke, 2001). While 
maintaining efficiency is key in the organization, it is a far cry from the rigid control that Taylor 
(1911) had envisaged or from Weber’s “monocratic bureaucracy” (Weber, Roth, & Wittich, 
1978). Efficiency’s main goal is not intended to solely improve financial outcomes, but is geared 
towards providing optimal customer service, ensuring that patients access their medications in a 
timely fashion, and providing clinical and counseling services as needed.  
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The structure of an organization “both enhances and constrains what an organization can 
accomplish” (Bolman & Deal, 2013, p. 50). Constraint, in my organizational context manifests at 
all levels of the organization. From a macro-perspective, healthcare in general and pharmacy 
practice specifically, carries with it ethical and moral obligations that require oversight, 
compliance, and regulation to ensure patient safety. This is in line with a philosophical theme 
where bureaucratic organizational models, with their division of labour, administrative 
regulations, and clearly established lines of authority and hierarchy play a critical role in 
organizational functioning (Du Gay, 2000; Weber, et al., 1978). However, bureaucratic and 
institutional rigidity can also act as an “iron-cage” that prevents the organization from fulfilling 
its obligations towards another key group; its shareholders (Adler, 2012; DiMaggio & Powell, 
1983; Mitzman, 1985). Community pharmacies in Canada are privately-owned for-profit entities 
that are accountable to their shareholders and have an obligation to exploit growth opportunities, 
reduce operating costs, and maximize profits. Seen through this lens, regulations and 
bureaucratic structures are obstacles towards the attainment of these organizational goals, a 
sentiment that is echoed in neoliberal thought (Davies, 2014a).  
At the micro-level, constraint, given the problem of practice, is ironically desirable 
because while each pharmacy team during a shift is expected to function autonomously, the 
amount of discretion that is afforded to employees is limited by their scope of practice. Viewed 
from this perspective, rules and structure serve as protection or control mechanisms that 
minimize errors and ensure patient safety. They however can also hinder efficiency and 
productivity, and one key challenge for the OIP is therefore to strike a balance in terms of 
constraint to ensure that rules and structure leverage and enhance employee effort by facilitating, 
instead of hindering it (Adler & Borys, 1996). In other words, one of the key objectives for the 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 18  
 
 
OIP will be to ensure that the “social architecture” of the organization is aligned with its mission, 
values, and goals (Bolman & Deal, 2013; Jones, Hesterly, & Borgatti, 1997; Lepak & Snell, 
1999; Nasra, 2018a).  
Structural tensions and dilemmas. A full assessment of the structural dilemmas and 
tensions in my organization as per the structural frame is not possible given the space limitations 
of this chapter. As such, I will address the most relevant elements of the analysis below.  
Differentiation vs. integration. The division of labour, the differentiation of employee 
roles, and the integration of efforts features greatly both in the structural frame as well as my 
problem of practice (Bolman & Deal, 2013; Nasra, 2018a). Since the introduction of the PT role, 
internal organizational data has revealed concerns directly related to these issues (Organization 
X, 2016a, 2017a). As noted earlier, pharmacy teams are comprised of three ‘types’ of employees 
with highly differentiated roles: pharmacists, PAs, and PTs. On any given day, a pharmacy team 
can be comprised of a pharmacist working with either a PT or a PA (Nasra, 2018a). As noted 
earlier, pharmacists can only delegate tasks to PTs but not PAs (see Table 1). Given the fast-
paced and highly task-oriented nature of the work, the frequent adjustments in the workflow that 
pharmacists must undertake depending on who they are working with often leads to suboptimzed 
performance (Bolman & Deal, 2013).   
Vertical and lateral coordination. Pharmacy teams operate as units and are expected to 
function autonomously during a shift, without having to resort to the Chief Pharmacist or senior 
management except for emergencies. Authority in a pharmacy team rests with the pharmacist 
who is the de-facto leader during a shift (Nasra, 2018a). That said, pharmacists and support staff 
must abide by rules, policies, regulations and standards that are set by the OCP, ParentCorp, as 
well as senior management in the organization. Senior management, myself included, put in 
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place performance plans and control systems that are intended to optimize performance as well 
as meet operational goals. For example, there is a specific number of medical reviews that the 
pharmacy team is required to perform per shift, in addition to meeting other performance metrics 
(e.g., amount of time to fill a prescription), both of which are examples of controlling 
performance (Mintzberg, 1979).  
Lateral coordination is key in the functioning of pharmacy teams. At the beginning of 
each shift, huddles take place to address and review expectations. Short handoff meetings 
between incoming and outgoing staff members are also conducted. To ensure the seamless 
transition between shifts, an overlap in support staff is deliberately designed into the schedule. 
While this does result in suboptimization of performance from a cost perspective, these overlaps 
enable support staff to act as boundary-spanners, ensuring that performance gaps between the 
transitioning teams are minimized (Bolman & Deal, 2013, p. 57; Dollinger, 1984; Williams, 
2002). This lateral coordination and overlap also improves workflow as the support staff is aware 
of any areas that require attention such as existing delays in processing prescriptions. As 
highlighted earlier, improper lateral coordination within pharmacy teams, such as delegating 
tasks to PAs, is one of the challenges facing my organization (Nasra, 2018a).  
Excessive autonomy vs. excessive interdependence. Each pharmacy shift acts as a 
standalone unit operating with high autonomy. These units can also be described as self-managed 
teams (Bolman & Deal, 2013). There is a high degree of interdependence between team 
members. A lack of coordination/integration of efforts, such as a pharmacist taking too long 
during counseling sessions, or support staff falling behind in entering prescriptions into the 
computer system, can lead to suboptimal performance and chaos. Even though it is unavoidable, 
this excessive interdependence of team members represents a risk and requires a high level of 
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communication, leadership and learning given the high-paced nature of the work being 
performed (Bunderson & Boumgarden, 2010; Zarraga & Bonache, 2005). Moreover, the 
excessive autonomy that these teams enjoy can lead to issues for the shift that follows. With each 
pharmacy team acting as a self-managed, standalone unit that is focused on getting through their 
shift, teams often leave a backlog of work for the team that follows. Rather than consider the 
pharmacy’s overall performance, group members sometimes focus too much on getting through 
a shift and providing the best care possible, that ensuring continuity and optimal workflow are 
over-ridden by the insularity of the shift despite having support members acting as boundary-
spanners to minimize those effects (Nasra, 2018a). These themes relating to the work of 
pharmacy team members will be revisited in the critical organizational analysis conducted in 
chapter two.  
Structural imperatives. Bolman and Deal (2013) highlight that each organization “needs 
to respond to a universal set of internal and external parameters”; what they refer to as structural 
imperatives (p. 62). These include size, core processes, environment, strategy and goals as well 
as the nature of the workforce. In my organization, pharmacy teams are small, which makes them 
typically simpler to manage. The high interdependence of team members, coupled with a high 
degree of role differentiation (i.e., the inability of support staff to take on pharmacist tasks) and a 
high degree of role overlap (see Table 1), however, increases the structural tensions within the 
organization and represents multiple points where one team member’s performance can lead to 
failure. The core processes of the pharmacy team are highly defined, but complex in nature. The 
high diversity in the types of tasks that pharmacists undertake is an extreme challenge that also 
slows down performance as pharmacists shift from one type of task to another (e.g., counseling 
patients, verifying prescriptions, managing workflow). The environment as described above is 
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highly paced and despite the routinized nature of the tasks, shifts can be extremely unpredictable, 
especially when dealing with patients whose treatment requires additional attention (e.g., drug 
dependence) (Nasra, 2018a).  
Recent Literature - Multilevel Factors Impacting the Problem of Practice 
The literature on the impact of legislative and regulatory changes in pharmacy remains in 
its infancy and scholarly studies are relatively limited and largely focus on the challenges and 
outcomes of these significant changes in pharmacy practice.  A comprehensive and systematic 
review of the literature on the changing scope of pharmacy practice initially revealed two broad 
themes: the barriers and challenges to the implementation of change, and the outcomes of 
change. As I elaborate below, most of the challenges and outcomes were found to be related to 
the perceptions, attitudes and behaviours of different stakeholders in the organization, and are a 
direct reflection of the central meso and micro discourses that shape the problem of practice.  
At the core of the micro symbolic-interactionist perspective is how individuals 
understand and ascribe meaning to their reality through social interactions (Blumer, 1980). 
Examining the root causes of the poor integration of PTs in pharmacy teams necessitates such 
micro-level inquiry and analysis. Moreover, such an examination can elucidate the changing 
social dynamics within pharmacy teams, as well as with patients. As stated earlier, organizational 
data suggests that patients often fail to distinguish between PAs and PTs and expect the same 
level of knowledge and service from both (Organization X, 2016a, 2017a). An assessment of 
organizational surveys also reveals that PAs feel pressured to counsel patients on health matters 
for which they are not trained, and they do so to avoid complaints and low customer satisfaction 
ratings (Organization X, 2016b, 2017b). This not only represents a grave concern for the well-
being of patients, but also serves to highlight the importance of examining the meaning and 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 22  
 
 
assumptions that people derive from their experiences, exchanges and environmental cues 
(Blumer, 1980; Carter & Fuller, 2016). It is interesting to note that these effects have also been 
reported in the literature as described below.  
The pharmacist perspective. Shifting from a product-focused/business-oriented role to a 
patient-focused/clinical-oriented role, as operationalized by the expanded scope of practice, 
essentially redefined the pharmacist role in the provision of healthcare products and services, and 
as such, it was not surprising that the key challenges and concerns that arose from this paradigm 
shift were related to role perceptions (Perepelkin & Dobson, 2009). The literature revealed that 
pharmacists in North America and Western Europe, for the most part, still consider their work in 
community pharmacies to be “for profit” and still view their interactions as taking place with 
customers or clients instead of patients (Austin, Gregory, & Martin, 2006; Perepelkin & Dobson, 
2009). In the community pharmacy field, there has been a long-standing tension and uncertainty 
in the professional orientation of pharmacists between their healthcare and business roles, which 
was further heightened by the expanded scope of practice of pharmacists (Perepelkin & Dobson, 
2009). 
According to Austin et al. (2006), the use of terms such as patient, client, customer, or 
consumer in pharmacy practice carries with it different interpretations of pharmacists’ roles and 
responsibilities, as well as varying perceptions of pharmacists’ autonomy and hierarchy in the 
organization which can have a significant impact on pharmacists’ interactions with the people 
they serve. Interestingly, recent studies suggest that pharmacists, despite their expanded scope of 
practice, still view themselves mainly as ‘dispensers of medication’ rather than as health care 
professionals (Rosenthal, Breault, Austin, & Tsuyuki, 2011). This belief is perhaps further 
reinforced by the fact that despite changes in remuneration practices, volume-based dispensing 
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of drugs continues to be considered by many organizations as a more stable and lucrative source 
of income than providing clinical services in the pharmacy (Rosenthal, et al., 2011).  
Other challenges that pharmacists face that were also examined in the literature included 
concerns pertaining to perceptions of the social legitimacy of their profession given its well-
established business-orientation; concerns about overlapping roles and responsibilities with 
physicians; as well as concerns regarding patient reactions which prevented pharmacists from 
offering clinical services to patients even when they believed they could be of benefit (Beales & 
Austin, 2006; Guirguis et al., 2014). These findings appear to suggest that the long-dominant 
business mindset has caused harm to the professional image of community pharmacists as 
healthcare providers, from the perspective of pharmacists, patients and other members of the 
healthcare industry (Beales & Austin, 2006).  
A few studies however did report some positive pharmacist perceptions and attitudes 
regarding their expanded role. For example, Makowsky, Guirguis, Hughes, Sadowski, and 
Yuksel (2013) found that pharmacists believed that there were important benefits to their new 
prescriptive authority such as the optimization of a patient’s treatment during their physician’s 
absence. Pharmacists also reported an increased sense of professionalism as health care 
providers, increased job satisfaction, and an overall improvement of their professional 
knowledge (Makowsky et al., 2013). In fact, confidence in clinical knowledge was found to be 
one of several critical factors that impacted pharmacists’ willingness to exercise their 
prescriptive authority (Roberts, Benrimoj, Chen, Williams, & Aslani, 2006). Other factors 
included autonomy, access to local networks of colleagues and external support (Roberts et al., 
2006).  
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The support staff perspective. During each shift, pharmacists and support staff work in 
close conjunction during the performance of their tasks (Nasra, 2018b). Even though the 
introduction of the PT role was meant to delegate technical tasks to PTs, the drug dispensing 
process still requires close collaboration and effective teamwork between the pharmacist and the 
PT, as they have complementary responsibilities for drug therapeutic appropriateness and 
technical accuracy, respectively (Nasra, 2018b). As a result, dissociating these two activities 
completely has been a challenge that has hindered the ability of the PT to relieve pharmacists’ 
time which could be otherwise dedicated to patient care and the provision of clinical services 
(Frost & Adams, 2017; Koehler & Brown, 2017; Lynas, 2011).  
Beyond challenges relating to workflow, research findings also appear to suggest that 
pharmacists exhibit a more pronounced sense of trust and respect for PTs than for PAs which can 
be explained in part by the technical knowledge that a pharmacist and a PT share because of their 
formal training (Bullock et al., 2016). Pharmacists also tend to view their relationship with PTs 
as being more collaborative in nature whereas their role with PAs as being more supervisory 
(Bullock et al., 2016). This differential treatment has been linked to lower levels of job 
satisfaction for PAs and other support staff who may feel undervalued (Inoue et al., 2016). These 
findings appear to be somewhat perplexing because despite valuing the role of PTs and their 
training, Bullock et al. (2016) found that the great majority of pharmacies looking to hire new 
support staff were more inclined to hire PAs than PTs.  Moreover, Schafheutle, Samuels, and 
Hassell (2008) found that while pharmacists had positive attitudes towards PTs, they still did not 
delegate tasks that could be carried out by PTs or other support staff.  
It was not surprising that the expanded scope of practice, and the introduction of the PT 
role were also found to be related to increased conflict among pharmacy team members. A recent 
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study by Gregory and Austin (2017) found that changes in the practice were related to role 
misunderstanding, threats to one’s professional self-identity and workplace demotivation. These 
outcomes could be attributed in part to personal differences, knowledge gaps, and a general lack 
of information sharing between pharmacists, PTs, and PAs (Gregory & Austin, 2017) which 
highlights the importance of considering the impact of regulatory changes from a human 
resources perspective (Cooper & Mohr, 2006).  
The patient perspective. Characterizing the relationship between pharmacists and those 
they serve is an important step in ensuring that the profession has shifted to a patient-oriented 
practice and that it is fulfilling the healthcare needs of society (Austin et al., 2006). A 2004 study 
conducted in Ontario suggested that, “in general, people who are served by the pharmacist do not 
see themselves as patients, but instead consider themselves to be customers or clients” (Verbeek, 
2004, as cited in Austin et al., 2006; Guirguis et al., 2014). This is significant for several reasons. 
Firstly, because it mirrors the same difficulty that pharmacists are experiencing in terms of their 
own self-perceptions, as indicated previously. Additionally, current regulations and legislation 
do not address the impact that changes in the provision of healthcare services have on their 
consumers. Interactions between a pharmacist and those seeking their products and services are 
dyadic and a major change that impacts the core function of one side of the interaction (i.e., 
pharmacists) which does not consider the other party (i.e., patients) will likely lead to a 
misalignment in expectations (Austin et al., 2006; Nasra, 2018b). Perepelkin and Dobson (2009) 
further highlighted the detrimental impact of the public’s ambiguous interpretation of the role of 
pharmacists, which they found vacillated between viewing pharmacists as healthcare 
professionals and seeing them as nothing more than business owners. The latter view can 
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significantly impede attempts to provide clinical services, as the public may consider that 
pharmacists are only doing so to benefit their bottom-line (Guirguis et al., 2014).  
Research into patient perceptions also revealed that the majority could not distinguish 
between trained pharmacists and PTs, and that they erroneously assumed that all support staff, 
including PAs, were equally knowledgeable and capable of addressing queries related to 
medications (Sheridan, Kelly, Basheer, Jan, & Lee, 2011).   
Table 2 
 
PEST Analysis  
Factor Application to Organizational Context 
Political  • Expanded Scope of Pharmacist Practice (Bill 179) 
• Transparent Drug System for Patients Act (Bill 102) 
• Pharmacy Technician role regulation 
• Tension between need for generating profit and 
delivering public services 
Economic  • Reduced revenue from prescriptions (Bill 102) 
• Revenue generated from billable clinical services:  
o Immunizations 
o Medscheck program 
o Rx renewal 
• PTs more expensive to hire than PAs as support staff 
• Corporate company budget restrictions 
• Financial performance metrics 
Social  • Role overlap between Pharmacists and PTs 
• Patient perceptions; inability to distinguish between 
support staff 
• Transactional exchanges between pharmacists and 
support staff 
• Support staff feeling undervalued 
• LMX: formation of ingroups (PTs) and outgroups (PAs) 
due to differential leader treatment 
Technological  • Workflow adjustments depending on whether pharmacist 
is paired up with PA or PT during shift 
• Pharmacists not delegating technical tasks to PTs 
• Pharmacists delegating tasks to PAs 
• Highly task-oriented work setting 
• Standard Operating Procedures not updated to consider 
evolving support staff roles 




Guiding Questions Emerging from the Problem of Practice 
While this OIP’s main focus and emphasis is my organization, the concerns raised by the 
problem of practice are not unique to it. The operational environment, more specifically the 
legislative and regulatory framework that my organization operates under, impacts all 
community pharmacies in Ontario, in other provinces as well as some countries where similar 
legislation exists (e.g., Austin et al., 2006; Perepelkin & Dobson, 2009). The problem of practice 
deals with a fundamental shift in pharmacy practice. Unfortunately, public data is not available 
to conduct a comparative analysis and explore whether other pharmacies are experiencing similar 
issues. The review of the academic literature, however, does provide some evidence that the 
questions raised in this OIP are shared by other organizations, and that the impact of the 
changing forces in pharmacy practice may be similar to what my organization is currently 
experiencing (e.g., Perepelkin & Dobson, 2009; Sheridan et al., 2011). As such, one emerging 
question that is useful for my OIP is: are there benefits from considering the problem of practice 
more globally as opposed to focussing solely on my organization? In a similar vein, given the 
wider implications for community pharmacy practice, is there a need for the concerns raised by 
this OIP to be elevated and brought to the attention of governing bodies such as the OCP or the 
Ontario Ministry of Health and Long-Term Care so that more comprehensive large-scale studies 
could be conducted? While this OIP unfortunately cannot tackle these important questions, they 
do help guide my thinking and analytical approach by contextualizing and embedding this OIP 
within its broader operational and social context. For instance, in conducting the critical 
organizational analysis in chapter two, it is essential that I consider all impacted stakeholders, 
both internal (i.e., employees) and external (i.e., patients). It is also essential that the chosen 
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solution be comprehensive and address all aspects of the problem of practice in order to 
maximize its chances of affecting meaningful change. 
Another guiding question for my OIP relates to the solutions that I can pursue, and the 
tension that exists between my organization’s private for-profit orientation, and the delivery of 
public, and sometimes government-funded, healthcare products and services. Given the 
limitations imposed by legislation and regulations, as well as the demands for profitability 
dictated by shareholders, how can I balance these opposing dynamics and at the same time come 
up with effective solutions that address my problem of practice? In other words, how do I tackle 
a complex issue with serious implications while remaining within a relatively small sandbox 
whose margins are imposed by public and private imperatives and demands? As will be noted in 
the critical organizational analysis in chapter two, this is an important and recurring question that 
manifests itself as an underlying theme for this OIP. One important implication for this question 
is that I could be limited in the scope of the changes that can be pursued, or that the solutions 
available to me may not be the most efficient or effective ones as identified by the organizational 
analysis.  
The implications of these emerging questions become even more evident as I begin to 
formulate this OIP’s vision for change and describe the current gaps and priorities for change in 
this following section. 
Leadership-Focused Vision for Change 
Organizational State and Gaps 
Since the introduction of the expanded scope of practice for pharmacists and the 
regulation of the PT role, internal organizational data, such as customer satisfaction surveys, 
employee engagement questionnaires as well as audit and incident reports, have revealed several 
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concerns summarized below (Organization X, 2016a, 2016b, 2017a, 2017b). These concerns 
represent the major gaps in organizational state that this OIP seeks to address.  
Workflow adjustments. Pharmacists who work with PTs can delegate some of their 
responsibilities (i.e., the technical aspects of prescription filling and validation) to PTs. However, 
due to the higher costs of hiring PTs (ParentCorp, 2018c), most of the support staff in our 
pharmacies, and most community pharmacies, are PAs (Bullock et al., 2016). As such 
pharmacists tend to be paired up with PAs frequently. When a pharmacist works with a PA, they 
need to adjust their workflow because task delegation cannot take place.  
The need to manage support staff differently on a regular basis depending on who a 
pharmacist works with during a shift poses a major challenge for a profession that is extremely 
task-oriented and fast-paced, and has been linked to pharmacist dissatisfaction (Lin, Leu, Breen, 
& Lin, 2008). Internal data, as well as research findings reveal that pharmacists often do not 
delegate any of the technical tasks to PTs when working with them in an effort to remain 
consistent and maintain the same workflow that they are accustomed to when working with PAs 
(Angelo & Ferreri, 2005; Organization X, 2016b, 2017b; Schafheutle et al., 2008). A more 
serious but related outcome of trying to avoid ‘shifting gears’ is the opposite scenario: some 
pharmacists who like the efficiencies achieved while working with PTs have been delegating 
technical tasks to PAs, who are not trained nor legally allowed to perform such tasks 
(Organization X, 2016b, 2017b). Internal data reveal that the consequences of workflow 
adjustments range from PTs feeling undervalued and unchallenged when their skills are not 
being utilized appropriately, to errors and potential legal violations because PAs are performing 
tasks beyond the scope of their expertise and training (Organization X, 2016b, 2017b). It is 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 30  
 
 
important to note that these findings mirror those that have been reported by researchers in the 
literature (e.g., Gregory & Austin, 2017; Hoxsie, Keller, & Armstrong, 2006; Inoue et al., 2016). 
A different level of service. Given that PTs are highly trained, they can address many of 
the technical questions regarding a patient’s prescription (NAPRA, 2014).  Patients have come to 
expect the same level of expertise from support staff and are usually not aware of the knowledge 
differences between PAs and PTs (Organization X, 2016a, 2016b, 2017a, 2017b; Perepelkin & 
Dobson, 2009; Sheridan et al., 2011). As a result, since the introduction of the PT role, internal 
organizational data revealed a significant decrease in customer satisfaction ratings for PAs in 
feedback surveys, often noting that PAs were not knowledgeable or helpful, in addition to higher 
rates of complaints lodged against PAs (Organization X, 2016a, 2016b, 2017a, 2017b). PA 
feedback survey responses suggest that PAs felt pressured to answer patient questions and to 
provide medical advice beyond the scope of their knowledge (Organization X, 2016b, 2017b). 
While the variability in the service that a customer can expect when they are being attended to is 
a significant source of concern to my organization, providing unqualified medical advice is a 
serious ethical violation that can endanger patients’ health and have severe consequences. 
Priorities for Change 
Addressing the core concerns raised in my problem of practice requires behavioural, 
structural, and process-based changes which will be integral to this OIP. More specifically, the 
issues below, which emanate from the current gaps in the organization, represent the 
organization’s main priorities for change: 
• Modifying and optimizing current workflows in the pharmacy to ensure efficiency 
and adaptation to the new PT role; 
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• Formalizing the role of PTs in the pharmacy team to best utilize their skillset and 
ensure their proper integration; and 
• Engaging with the public about the roles that different pharmacy team members play 
as well as the clinical services that are available to them. 
These priorities will be at the core of the detailed organizational change plan and 
recommendations that will be put forth in chapters two and three. These priorities also represent 
the key to balancing the needs of both internal and external stakeholders. For example, the 
modification and optimization of pharmacy workflows will focus on ensuring patient safety 
while at the same time maintaining efficiency. Similarly, engaging with patients will not only be 
beneficial in terms of educating them about the functions of the pharmacy, but will also 
explicitly address issues related to role perceptions, which were summarized in the literature 
review, and which could help mitigate some of the behaviours that have contributed to the 
problem of practice. 
Change Drivers 
Kotter’s (2012) change model highlights the importance of “building a guiding team” 
within the organization. For a change initiative to be successful it is critical to have champions 
who act as change drivers within the organization. In my organization, this guiding team would 
consist of myself, the other partner and Chief Pharmacist, as well as representatives from our 
pharmacist and support staff cadres. Involving employees at every step of the OIP will set the 
stage for these organizational members to act as change agents (Cawsey, Deszca, & Ingols, 
2016) who help facilitate buy-in and create a sense of engagement and ownership over the 
change initiative (Hoadley & Lamos, 2012).  
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With the guiding team taking on a leadership role, it is essential to develop a clear vision 
of where the organization needs to be (i.e., the future desired state). Putting forth an achievable 
vision that is agreed upon by various stakeholders and that embodies the organization’s values 
and goals also helps achieve a shared organizational understanding of the overall change 
initiative and can galvanize all stakeholders in support of those goals (Calegari, Sibley, & 
Turner, 2015). In addition to being change agents, having representatives from every employee 
group in the leadership team can further facilitate the change effort by monitoring progress and 
identifying the core challenges that may arise throughout the implementation of the OIP (Nasra, 
2018a).  
Organizational Change Readiness 
Change initiatives, no matter how well-planned, can be derailed if an organization is not 
ready for change. The factors that have precipitated the organization’s current state, as well as 
those that have contributed to symptoms of the problem of practice, are structural and social in 
nature and they originate from both outside and within the organization. It is not surprising 
therefore that when assessing an organization’s change readiness, both internal and external 
forces need to be examined, and that systems and people are fundamental to such an assessment 
(Cawsey et al., 2016; Freeman, Wicks, & Parmar, 2004; Judge & Douglas, 2009).  
Armenakis, Harris, and Mossholder (1993) highlight that change readiness is reflective of 
organizational members’ “beliefs, attitudes, and intentions regarding the extent to which changes 
are needed and the organization’s capacity to successfully make those changes” (p. 681). In my 
organization, this highlights the importance of engaging the key stakeholders in the change 
process and ensuring their buy-in and active participation (Holt, Armenakis, Field, & Harris, 
2007; Kotter, 2012; Kotter & Cohen, 2002; Lewis, 2019). While the organization’s financial and 
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operational performance (e.g., dispensing error rates) is certainly important for shareholders and 
ParentCorp, the problem of practice’s implications are clearly manifested and can be directly 
observed at the individual level, with pharmacists and support staff being the key players that 
will be impacted by the change initiative. It is essential therefore that the OIP carefully considers 
not just the organization’s, but also the individuals’ readiness for change (Cawsey et al., 2016; 
Weiner, 2009).  
In my organization, it may seem ‘evident’ for the management and leadership team that 
change is necessary. Increased demands on pharmacists, the poor integration of pharmacy 
support staff, and higher error rates are all indicators that all is not well. Leadership, however, 
should not take for granted that organizational members will simply be on-board, or that they 
inherently understand “why” change is necessary (Beckhard & Harris, 1987; Cawsey et al., 
2016). The complexity and multi-dimensional nature of organization change is further 
highlighted by Judge and Douglas’s (2009) model for assessing an organization’s capacity for 
change. Judge and Douglas (2009) suggest that eight separate but correlated dimensions impact 
organizational change readiness: trustworthy leadership; trusting followers; capable champions; 
involved middle management; innovative culture; accountable culture; effective 
communications; and systems thinking. These dimensions highlight the comprehensive and 
complex nature of organizational change, and how critical it is that organizations adequately plan 
and prepare for it. 
Part of preparing for organizational change is understanding the internal and external 
forces that are currently at play and can shape and determine the outcomes of the change 
initiative (Cawsey et al., 2016; Holt et al., 2007). While internal and external forces may imply 
that they are in “opposition”, in truth, any such force may have the ability to facilitate, constrain 
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or block change efforts (Cronshaw & McCulloch, 2008). It is therefore imperative for this OIP to 
examine in detail the impact that each force will have. 
From an external perspective, the most dominant forces that will inform, and to a certain 
degree constrain, the change plan include the provincial and governing body regulations that 
impose restrictions and obligations on the pharmacy as a whole, and on the role that each 
pharmacy staff member can play. As such, it will be important to examine the scope of what 
possible and meaningful change looks like within the confines of what has been prescribed by 
regulatory bodies and government policies. Similarly, operational guidelines that are set by 
ParentCorp, as well as budgets and fiduciary obligations will also have a significant impact on 
any change plans. For example, hiring new support staff members, or changing the composition 
of pharmacy teams will be limited to the extent that the organization’s operational budget 
permits it. Finally, as was evident in the review of the literature, one cannot underestimate the 
role that patient perceptions, attitudes, and expectations will have on any change in the 
organization. As was highlighted earlier, the introduction of the PT staff resulted in the confusion 
of patients who could not differentiate between PTs and PAs, which precipitated some of the 
unintended consequences of this change (Sheridan et al., 2011). As such, any proposed changes 
in the pharmacy will need to take into account how they will be received, and perceived, by the 
public and whether any additional measures need to be put into place, such as communication or 
information campaigns, to counteract any potential problems.  
Internally, the most important forces that the OIP needs to take into account are employee 
perceptions and attitudes. Pharmacy staff are the most critical stakeholders in this OIP, and the 
success or failure of any change initiative rests on their buy-in and commitment. While patient 
safety and satisfaction were an important symptom of the problem of practice, the main causes 
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relate to the significant operational changes that impacted pharmacy staff, and how those 
changes translated into their daily work. As such, the OIP needs to take into account employee 
perceptions at every stage of the change plan, by engaging them and soliciting their feedback on 
a regular basis. The organization’s leadership team also represents a significant internal force 
that will shape the OIP. As outlined earlier, one of the opportunities that this OIP presents is the 
ability to affect change in the prevalent forms of leadership that are currently exercised. The 
leadership team will also play a critical role in communicating both internally and externally and 
will be central in every aspect of the change plan (Cawsey et al., 1996; Goodman & Truss, 2004; 
Kotter, 2012). Finally, the role of internal resources in the organization cannot be overlooked or 
underestimated. The functioning of the pharmacy is dependent on human, physical, and financial 
resources, and it is therefore expected that resources will play both an enabling and constraining 
role in the OIP, which will be mediated by the leadership team who have control over resource-
related decisions. When considering all of the above factors, and as will be evidenced by the 
detailed organizational analysis in chapter two, the organization is not only ready for change, but 
given the implications of the problem of practice, change is urgently needed. 
Chapter Summary  
 This chapter introduced the problem of practice and contextualized it within the historical 
and organizational factors that underpin this OIP. The chapter also identified the prevalent forms 
of leadership within the organization and highlighted the current gaps that the OIP seeks to 
address. By reviewing and summarizing the relevant literature and framing the problem of 
practice using Bolman and Deal’s (2013) structural frame, I was able to identify the main 
considerations that influence and shape the problem of practice. These factors form the 
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foundation of the vision for change that was also introduced, and which will be explored in depth 
in chapter two. 
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Chapter 2: Planning and Development 
Chapter one of the OIP provided the contextual and theoretical background, framing the 
problem of practice. In this chapter, the emphasis moves from describing the need for change to 
establishing the foundations for planning change. This is done by exploring the role of leadership 
in organizational change and how it can inform and guide the change process. An in-depth 
review and examination of Kotter’s (2012) framework for organizational change, followed by a 
critical organizational analysis using Nadler and Tushman’s (1980) Congruence Model highlight 
the OIP’s approach to change and puts into focus the areas of the organization that are in need of 
improvement. I then proceed to consider several possible solutions that can be pursued to address 
the problem of practice by weighing their strengths and limitations. The chapter concludes by 
examining the ethical dimensions as they relate to organizational change and the specific context 
of this OIP.  
Leadership Approach to Change 
To successfully address the problem of practice, any proposed solution or initiative for 
change must be borne out of and reinforced by leadership that is aligned with both organizational 
and individual leadership. As introduced in chapter one, the two most prevalent forms of 
leadership in the organization are transactional leadership and LMX. Given the nature of the 
tasks that are performed in the pharmacy, moving away entirely from transactional leadership, 
especially for daily operations, would be problematic if not impossible. My personal leadership 
style, however, is anchored around the strong belief in empowering others and being supportive 
and authentic in my interactions with employees (Nasra, 2018a). The gap that currently exists 
between my individual leadership style and organizational leadership represents an important 
opportunity that can be leveraged during the change process. To that end, this section will 
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emphasize how elements of transactional leadership essential to organizational functioning can 
be combined with relational leadership behaviours (Bauer & Erdogan, 2015) can be harnessed to 
promote organizational change.  
Transactional Leadership 
Transactional leadership, at a rudimentary level and as the theory’s name suggests, 
involves the use of rewards in order to achieve results and is based on the principles of exchange 
and reciprocity (Burns, 1978). “Transactional leadership occurs when one person takes the 
initiative in making contact with others, for the purpose of an exchange of valued things” (Burns, 
1978, p. 19). This form of leadership is based on setting objectives, clear rules and regulations, 
and establishing formal lines of authority. Transactional leadership, as it is conceptualized today, 
is often viewed as part of a “full-range” model of leadership (Bass, 1985) that also includes 
laissez-faire and transformational leadership (Antonakis & House, 2014; Avolio & Bass, 2002; 
Bass, Avolio, Jung, & Berson, 2003; Jensen et al., 2019; Judge & Piccolo, 2004). Transactional 
leadership, as conceptualized in theory, comprises three components: contingent reward, 
management by exception-active, and management by exception-passive (Avolio & Bass, 2002; 
Jensen et al., 2019; Judge & Piccolo, 2004). Contingent reward is “the degree to which the leader 
sets up constructive transactions or exchanges with followers: the leader clarifies expectations 
and establishes the rewards for meeting these expectations” (Judge & Piccolo, 2004, p. 755). 
Management by exception involves leader intervention, and the difference between its passive 
and active forms has to do with when the intervention occurs (Howell & Avolio, 1993). In active 
management by exception “leaders monitor follower behavior, anticipate problems, and take 
corrective actions before the behavior creates serious difficulties” whereas passive leaders wait 
until the behavior has become problematic before taking action (Judge & Piccolo, 2004, p. 756).  
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In the context of my organization, standards, rules, and procedures abound and are 
essential to the daily functioning of the pharmacies. They are set by governing regulatory bodies 
(e.g., OCP), ParentCorp, and internally. Given the highly regulated nature of the business, and 
the serious ramifications of errors, collectively, these “tools” are put in place to ensure patient 
safety. In order to proactively reduce errors, workflows and SOPs are incorporated within the 
information technology (IT) system used in the pharmacy and are actively monitored by the 
pharmacist on shift. The pharmacist also interjects as needed to address any workflow issues 
(e.g., backlogs, delays). Despite these controls, errors do occur, and in these situations, it is the 
leader’s responsibility to remedy the mistakes, and to log and report them accordingly. All the 
above represent traditional examples of both active and passive management by exception 
(Howell & Avolio, 1993). Moreover, both pharmacist and support staff receive annual financial 
incentives that are contingent on performance metrics which are set at the beginning of each 
fiscal year, such as customer satisfaction ratings and the number of medical reviews and clinical 
services performed (ParentCorp, 2018c). Any proposed solutions to the problem of practice will 
need to maintain these transactional leadership elements given that they are fundamental to the 
operation of the organization. The highly transactional nature of the work, however, does not 
imply that leader-follower exchanges and relations cannot be improved and enriched through the 
change initiative, which will be explored next.  
Relational Leadership – LMX  
LMX theory is founded on the premise that leaders’ interactions with followers are 
differentiated (Day & Miscenko, 2015; Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995; 
Scandura & Graen, 1984). Prior to the introduction of LMX’s precursor, vertical dyad linkage 
(VDL) theory in 1975, the prevailing leadership models assumed that leaders interacted with 
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their followers in a uniform manner and had homogeneous perceptions, behaviours and reactions 
(Dansereau, Graen, & Haga, 1975; Graen & Uhl-Bien, 1995). VDL theory challenged that view 
and posited that leader behaviors progress and change through interacting with followers and that 
these interactions were not uniform, but unique to each leader-follower dyad (Dansereau et al., 
1975). LMX theory built on this concept of relationship differentiation and viewed that the 
quality of the relationship between leaders and followers was central to understanding leader 
effects on followers, teams, and organizational outcomes (Bauer & Erdogan, 2015; Day & 
Miscenko, 2015). 
According to LMX theory, leader-follower interactions span a continuum that ranges 
from basic “economic exchange” interactions that do not go beyond job-descriptions (low-
quality) to “social exchange” relationships characterized by trust and respect (high-quality) 
(Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995; Pellegrini, 2015). “Economic exchange” 
interactions have also been described as transactional in the literature (Bauer & Erdogan, 2015; 
Day & Miscenko, 2015; Erdogan & Bauer, 2014). It is important to note that while there are 
overlaps with transactional leadership, economic exchange or transactional exchanges in LMX 
theory are referred to as such to imply a lack of social investment on the part of the leader and 
the follower in the relationship, and that these interactions rarely go beyond what job 
descriptions dictate (Pellegrini, 2015). Whereas transactional leadership theory is concerned with 
leader behaviours, LMX theory focuses on the quality and the nature of the relational exchanges 
and dynamics between the leader and follower. Given the above, even a high performing 
employee according to transactional leadership theory, could be described as having low-quality 
exchanges according to LMX theory. This is pertinent to the OIP because as mentioned earlier, 
transactional processes are “built into” organizational operations. By focusing on the quality of 
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the exchanges that employees and leaders have, the OIP can leverage LMX theory to address 
some of the concerns outlined in the problem of practice. In adopting this approach, I am also 
able to emphasize those aspects of my leadership style that are relational in nature and that focus 
on employee empowerment and engagement, as described in my leadership position statement in 
chapter one. 
Over the last decade, LMX scholars have turned their attention to exploring what factors 
can enhance leader-follower relationship quality (Martin, Guillaume, Thomas, Lee & Epitropaki, 
2016). Several studies have found that leader delegation can build trust and is related to higher 
LMX quality (Bauer & Erdogan, 2014; Bauer & Green, 1996; Yukl, O’Donnell, & Taber, 2009). 
This is highly relevant to my OIP as task delegation between pharmacists and PTs has been 
identified as an area that needs to be addressed given that pharmacists are not delegating tasks 
properly. Other factors that can improve LMX relationship quality include: showing empathy 
towards followers (e.g., Mahsud, Yukl, & Prussia, 2010); expending effort in building the 
relationship (e.g., Maslyn & Uhl-Bien, 2001); increasing perceived fairness in interacting with 
followers (e.g., Erdogan, Liden, & Kraimer, 2006; Masterson, Lewis, Goldman, & Taylor, 
2000); and behaving ethically (e.g., Mahsud et al., 2010; Walumbwa, Cropanzano, & Goldman, 
2011). All these factors are highly pertinent to my organizational context and OIP.  
As highlighted earlier, transactional leadership elements are built into the organization’s 
operations. They are imposed through regulatory bodies as mechanisms to ensure patient safety 
and compliance with regulations. Accordingly, and regardless of personal leadership style, 
leaders in the organization, due to structural elements of the operational environment (Bolman & 
Deal, 2013), must engage in transactional exchanges with followers as part of their regular tasks. 
In fact, pharmacists themselves who are the de-facto leaders during each shift, are also subject to 
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the same constraints that govern their work. Put differently, the operational environment, through 
its regulation, standards, rules, procedures and workflows, structures how leaders and followers 
interact and perform their jobs. On the other hand, the interpersonal dyadic exchanges that take 
place during and outside of work shifts, are influenced and shaped by relational variables such as 
trust, fairness, engagement and cooperation that are rooted in social exchange (Blau, 1964). 
Social exchange theory dictates that when leaders behave in supportive ways that are beneficial 
to followers, it motivates employees to behave in a reciprocal manner that is beneficial to the 
leader (Martin et al., 2016). Through reciprocal mutually beneficial interactions, leaders and 
followers improve the quality of their exchanges, at times going above and beyond what is 
expected of them (Erdogan & Bauer, 2014; Erdogan, Sparrowe, Liden, & Dunegan, 2004; Graen, 
Novak, & Sommerkamp, 1982). Figure 1 below depicts how both transactional leadership and 
relational behaviours (derived from LMX) manifest themselves in my organization and can be 
leveraged in the OIP. 
 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 43  
 
 
By engaging in both transactional and interpersonal leadership interactions with 
followers, leaders in the organization display a hybrid Structured Relational Leadership style 
that incorporates elements of both leadership theories. As can be noted in Figure 1, those aspects 
of SRL that correspond to transactional leadership can be categorized as “managing” behaviours, 
while elements of SRL concerned with interpersonal aspects of LMX can be described as 
“engaging” behaviours. Both classes of behaviours are essential to the OIP given that the 
problem of practice requires paying attention to the processes and mechanisms (i.e., structures) 
that govern tasks to avoid errors and maximize efficiency, as well as ensuring that employees are 
motivated and satisfied. Moreover, elements of my personal leadership style are also featured in 
the social exchange end of the LMX continuum,  and as will be described in later sections of this 
chapter and in chapter three, communication and building trust are fundamental to the 
implementation of the change plan, especially since employee morale and engagement are key 
considerations for my OIP. 
Framework for Leading the Change Process 
The Change Management literature offers several models and frameworks that could be 
leveraged to implement change in organizations; each with its own strengths and limitations. 
Selecting the appropriate framework to use should be guided in part by the model’s ability to 
provide the appropriate level of insight into the OIP. In my organizational context, the changes in 
pharmacy practice that have precipitated some of the negative outcomes observed are best 
described as radical change.  This type of change, which can also be described as a paradigm 
shift, involves major transformations in how things are done within an organization (Armenakis 
& Bedeian, 1999; By, 2005; Greenwood & Hinings, 1999). Other key considerations I weighed 
when evaluating change models was their ability to handle change that is complex and 
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multifaceted. Given the above, my review of the literature determined that Kotter’s (2012) 
change model resonates with the current reality of my organization, where a sense of urgency has 
already been established due to the nature of the operational changes that are unfolding, as well 
as the seriousness of some of the outcomes (i.e., impact on patient health) (Kotter & Cohen, 
2002; Nasra, 2018a). Determining how change must be implemented in the organization is 
equally important to recognizing that change is needed in the first place (Kotter & Schlesinger, 
2008) and Kotter’s (2012) model represents a phase-driven strategic approach that highlights 
structural and procedural change both of which are critical to the OIP. More specifically, the 
framework operationalizes the change process and provides a road map that can be followed for 
implementing change (Pollack & Pollack, 2015).  
Kotter’s Change Framework 
Kotter’s change framework proposes eight distinct steps or phases that are required to 
achieve successful long-term change within the organization (Kotter, 2012; Kotter & Cohen, 
2002). These eight steps were identified to counter the eight common errors that leaders commit 
that undermine any change initiative or transformation process (Kotter, 2007, 2012). Below, I 
describe in detail Kotter’s (2012) logical eight-step model and its application to my OIP.  
Establishing a sense of urgency. The first step in Kotter’s (2012) framework is 
concerned with highlighting the pressing need for change in the organization. Like Cawsey et 
al.’s (2016) “awakening” phase, this step is critical because it motivates stakeholders by 
emphasizing the gaps between the current and desired organizational states, and the impact that 
inaction will have on the organization. In my context, the radical changes that have reshaped the 
field of pharmacy practice on their own represent a pressing need for organizational change 
(Lynas, 2011; OCP, 2012). When considering the additional symptoms of increased errors and 
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the risk they pose to patient safety, lowered employee job satisfaction, and higher number of 
patient complaints (Organization X, 2016b, 2017b), the need for change and remediation to 
correct these concerns becomes all the more pressing and urgent. As such, both management and 
employees are already aware of the urgent need for change, however, further urgency could be 
emphasized by senior leadership through communication leading up to the implementation of the 
change plan, which will be detailed in chapter three, as well as during the annual employee 
performance reviews and the posting of pharmacy performance metrics and highlighting the 
increasing error rates and lowered patient satisfaction ratings.  
Creating a guiding coalition. For a change initiative to be successful it is critical to have 
champions who act as change drivers within the organization (Cawsey et al., 2016). Leaders on 
their own cannot affect permanent change (Kotter, 2012). Change drivers need to be 
organizational members who have proven leadership expertise, are credible and trusted, and 
possess position power (Calegari et al., 2015; Kotter, 2012). I also believe that for change to be 
effective, employees should feel that their voices are heard, and having employee representation 
in the guiding team will facilitate communication and enable trust (Calegari et al., 2015; Hoadly 
& Lamos, 2012). Accordingly, in my organization, the change implementation plan will involve 
the creation of guiding leadership teams that would consist of myself, the other partner and Chief 
Pharmacist, as well as representatives from the pharmacist and support staff cadres. Involving 
employees at this early stage ensures that they act as change agents (Cawsey et al., 2016) who 
help facilitate buy-in and create a sense of engagement and ownership over the change initiative. 
As will be detailed in chapter three, the guiding teams will play a critical role in all aspects of 
planning and implementing the change plan as well as a central role in the communications plan. 
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The implementation plan will also include key stakeholder consultations at various stages, which 
will further enable employee engagement and participation in the change initiative. 
Developing a vision and strategy. With the guiding coalition taking on a leadership role, 
it is essential to develop a clear succinct vision of where the organization needs to be (i.e., future 
desired state) (Kotter, 2012). Simply highlighting the need for change and emphasizing its 
urgency is not enough. Effective leadership entails creating a vision and strategy for 
organizational change that can serve as a compass that guides the organization through 
challenges and unpredictability (Leavy, 2012). A clear vision and strategy generate a sense of 
purpose, commitment and direction (Kotter, 2012). As will be elaborated in chapter three, the 
vision and strategy for change will be developed by senior leadership along with employee 
representatives who together will form the guiding teams. Moreover, putting forth an achievable 
vision that is agreed upon by various stakeholders and that embodies the organization’s values 
and goals helps create a shared organizational understanding of the overall change initiative and 
can galvanize all stakeholders in support of those goals. Accordingly, and as will be outlined in 
the communications plan, employee consultation will take place on a regular basis, with the 
guiding team seeking employee input at various stages in the implementation plan. Patients as 
key stakeholders will also be heard as their feedback on the effectiveness of the change plan is 
also an integral part of the evaluation and the monitoring components of the OIP, as will be 
discussed in chapter three.  
Communicating the change vision. Successful leaders can articulate and communicate 
the vision for change clearly throughout the organization, and in the process generate buy-in and 
motivate employees to contribute to the change initiative (Kotter, 2012; Leavy, 2012). Chapter 
three will provide at a granular level the communication strategy that will be employed during 
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the implementation of the change plan. Having open communication channels and 
communicating regularly and extensively enables the change drivers to maintain the same level 
of urgency throughout the change effort (Klein, 1996). Communication also allows the guiding 
team to provide updates as they monitor progress, raise awareness, and ensure continued 
employee engagement which is critical for engagement and can further enhance employee 
commitment to the change effort (Kotter, 2012; Reissner, Pagan, & Smith, 2011). During the 
implementation stage, it is therefore essential for the guiding teams to promote trust and 
openness, and by communicating the change vision effectively, employees begin to feel that they 
are directly involved in the change effort which can further enhance their readiness for change 
(Cameron & Green, 2004; Jimmieson, Peach, & White, 2008; Kotter, 2012). The communication 
plan that I developed emphasizes that all organizational members should be familiar with the 
change vision and strategy and that messaging should be reinforced repeatedly, especially by the 
pharmacist and support staff representatives of the guiding teams (Appelbaum, Habashy, Malo, 
& Shafiq, 2012; Armenakis & Harris, 2002; Kotter 2012).  
Empowering employees for broad based action. Kotter’s fifth step is all about enabling 
action and removing obstacles (Kotter, 2007). In addition to being change agents, the guiding 
coalition teams need to facilitate the change effort by monitoring progress and identifying the 
core challenges that may arise throughout implementation and putting forth concrete plans to 
resolve them. As such, a robust monitoring and evaluation plan was specifically designed for this 
purpose and will be described in detail in chapter three. Moreover, empowering employees 
involves getting rid of existing systems or barriers that undermine the change vision (Kotter, 
2007, 2012). As such, as will be noted in the critical organizational analysis in the following 
section, I paid special attention to the structural elements of the organization (e.g., SOPs, 
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workflows) that have contributed to low employee morale and ensured that those elements were 
addressed in the proposed solutions. Empowering employees is also critical in the 
implementation of the change plan, as such, senior leadership in the organization (i.e., myself 
and the Chief Pharmacist) need to ensure that any required resources are made available, for 
example by providing necessary resources and incorporating the change plan costs into the 
organization’s budget. By empowering the guiding teams, organizational leaders would not only 
be facilitating the implementation of the change strategy, but they also give employees a sense of 
control and ownership which can only enhance their support and buy-in and improve their 
adaptability to change (Jimmieson et al., 2008; Kotter, 2012).  
Generating short term wins. Kotter (2007, 2012) highlights the importance of dividing 
the change process into distinct phases in order to plan for visible improvements and create short 
term wins. By monitoring and evaluating progress, the leadership team can adapt plans based on 
the level of progress that is being achieved (Kotter, 2012; Mento, Jones, & Dirndorfer, 2002). As 
such, highlighting progress and key milestones feature greatly in the implementation plan, as 
well as in the monitoring and evaluation strategy described in chapter three. At a high level, 
throughout the change initiative, this would involve the guiding teams reviewing periodic 
performance metrics, customer survey data, and employee satisfaction indices and sharing any 
improvements with employees on a regular basis. In addition to adapting plans and making the 
required course corrections, this phase in Kotter’s framework enables the guiding team to 
recognize and celebrate achievements, which further empowers and motivates employees and 
improves engagement, thereby sustaining the change effort (Kotter, 2012).  
Consolidating gains and producing more change. Kotter (2007) cautions leaders about 
“declaring victory too soon” during the change initiative. Instead, during this seventh step, it is 
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critical that leaders develop the appropriate systems, processes and procedures in support of the 
change vision. Using the credibility generated by the short-term wins, the guiding coalition 
should assess the progress that has been made, as operationalized in the monitoring and 
evaluation strategy, and endeavour to change all the systems and structures that are no longer 
aligned with the new vision. Other changes that should be implemented during this stage include 
developing, promoting, or hiring organizational members who can further implement the change 
plan and reinvigorate the change process (Kotter, 2007, 2012). These actions are required 
because oftentimes, employees who are resistant to change may not publicly oppose it during the 
early stages, and instead wait for the right opportunity and time to hinder progress, a point I will 
revisit in chapter three (Kotter, 2012). Moreover, given that the change initiative would have 
been ongoing for some time, it is easier for employees at this stage to become complacent and 
fall back into the old way of doing things (Kotter, 1998, 2012). As such, the guiding team and 
leaders need to expend additional effort and resources in order to maintain momentum and see 
through the transformation process. As progress is achieved, employees’, and sometimes 
leaders’, sense of urgency may wane as other priorities pop up which can threaten the long-term 
success of the overall change project (Kotter, 2012). As such, both the implementation and 
communication plans that I developed explicitly address these concerns and attempt to mitigate 
them. 
Anchoring new approaches. The final stage in Kotter’s (2012) framework is similar to 
Cawsey et al.’s (2016) “institutionalization” or Lewin’s “refreezing” steps. Once systems and 
procedures have been put in place, it is incumbent upon the leadership team to explicitly 
demonstrate how the new “way of doing things” is tied to organizational outcomes. This not only 
reinforces change, but also ensures that organizational members understand how the overall 
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initiative has contributed to closing the gap between the organization’s initial state and its desired 
state. Within my organization, this translates to leaders taking concrete steps to make the new 
organizational reality a part of the organization’s operations. This can be achieved in different 
ways such as highlighting improved organizational performance (e.g., metrics), and 
demonstrating the positive impact that new processes have on employees. A more tacit way in 
which my change plan ensures that change is lasting is directly tied to the actual proposed 
solutions which involve structural changes in how tasks in the pharmacy are performed 
(workflow), and which would be very difficult to reverse. What is critical in this step is that all 
organizational members begin to view the new organizational state as “the new reality” and 
cease to think of the new processes as being a part of an organizational change initiative. By not 
implementing this step, many organizations fail at sustaining the change effort (Kotter, 2007, 
2012). 
Critical Organizational Analysis 
One of Kotter’s (2012) framework’s limitations is that it does not explicitly have an 
organizational analysis phase as other change models do (e.g., Cawsey et al.’s, (2016) Change 
Path Model; Beckard & Harris’s (1987) Change Management Process). Conducting a critical 
analysis that will explore in detail all the factors impacting the organization, and by extension the 
problem of practice, is one of the most important elements of an OIP. As such, selecting the 
appropriate frameworks and tools to conduct the organizational analysis critical. As described in 
chapter one, and by reviewing the findings of the PEST analysis (see Table 1), it becomes 
evident that both external and internal factors have precipitated the symptoms of the problem of 
practice and current organizational state. As such, it is imperative to study the organization 
utilizing a holistic systems-based perspective. Nadler and Tushman (1980) describe this 
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diagnostic stage as the “collection, integration, and analysis of data about the organization and its 
environment” (p. 197). Nadler and Tushman’s (1980) Congruence Model is rooted in systems 
theory (Katz & Kahn, 1978; von Bertalanffy, 1950) and examines the organization’s context, its 
transformational processes and outputs, and as such was selected as the framework for this OIP’s 
organizational analysis. 
The Congruence Model 
Open systems theory examines the interactions and outcomes of the various components 
that comprise a particular system (von Bertalanffy, 1950). Katz and Kahn (1978), in their 
seminal work The Social Psychology of Organizations further elaborated by describing open 
systems as being comprised of one or more “cycles” that take in inputs, transforms them, and 
produces outputs. The authors suggested that by considering organizations as open systems, 
scholars would be able to gain a better understanding of the way that people behave and interact 
in organizations (Katz & Kahn, 1978). Such a view of organizations, while extremely 
enlightening, required further elaboration to better understand how organizations as open 
systems functioned (Kast & Rosenzweig, 1972). Nadler and Tushman’s (1980) Congruence 
Model provides a detailed and specific framework that allows for understanding the organization 
at multiple levels of analysis by examining sub-systems within the organization. Moreover, the 
Congruence Model posits that for organizations to be effective, they must constantly evolve 
through management and restructuring (Nadler & Tushman, 1980). The presence of misaligned 
processes and structures within the organization leads to inefficiencies and undesirable 
outcomes. This is where the concepts of “fit” and alignment between the various units and 
processes of the organizational system become key (Nadler & Tushman, 1980). Organizations 
whose sub-systems (i.e., units) are congruent and fit well together function in an optimal way. 
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By extension, the presence of incongruence leads to problems in organizational functioning 
(Nadler & Tushman, 1980). Figure 2 below summarizes the organizational analysis that I 
conducted using the Congruence Model. 





Figure 2. High level application of organizational congruence model. Adapted from Nadler, D. A., & Tushman, M. L. (1980). A model 
for diagnosing organizational behavior. Organizational Dynamics, 9(2), 35-51. 
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According to the Congruence Model, organizations are comprised of the following 
components: tasks, individuals, and both formal and informal organizational structures (Nadler 
& Tushman, 1980). While Figure 2 allows for a high, systems-level view of the organization, the 
details relating to each component, as well as the analysis of the fit between the different 
elements are provided below. 
Inputs. There are multiple factors that impact the organization which require careful 
consideration. The PEST analysis conducted in chapter one (see Table 1) reveals that the 
expansion of the scope of practice for pharmacists through Bill 179 and the regulation of the PT 
role represent significant political shifts that have had considerable impact on the tasks of 
employees and the overall functions of the pharmacy (OCP, 2012; OPA, 2014). Another political 
tension centres around the need to balance the organization’s revenue-generating activities (i.e., 
for-profit orientation) and the imperative to provide an essential public service without 
restrictions (Nasra, 2018a, 2018b). This is directly tied to the economic forces that shape and 
influence the organization’s operations which include a reduction in revenue as a result of the 
implementation of Bill 102 which eliminated professional allowances and rebates (Grindord et 
al., 2013; Rosenthal et al., 2012; VanderElst, 2010). On the other hand, the provision of clinical 
services such as immunizations and conducting medical reviews represent new revenue-
generating activities that also influence the organization. Other economic factors that influence 
the organization also fall under the category of resources and are related to the cost of hiring 
support staff and budgetary restrictions. In 2018, the average starting wage for PTs was $22.30 
while PAs earned $14 (ParentCorp, 2018d).  Hiring PTs therefore represents a significant 
investment and cost that needs to be weighed carefully. In addition to fiduciary obligations (i.e., 
generating profit), the parent company and the franchisees/parnters, myself and the Chief 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 55  
 
 
Pharmacist, set annual operational budgets and monitor financial performance metrics on a 
regular basis.  
There are several social factors that impact the organization which were explored in 
depth in chapter one. These included the issue of role overlap between pharmacists and PTs 
(Beales & Austin, 2006) and the tensions that arise as a result. The inability of patients to 
distinguish between support staff has also been identified as an important issue related to patient 
perceptions which contributes to the symptoms of the problem of practice (Nasra, 2018a). The 
transactional nature of leader-follower exchanges is another social factor, as is the differential 
treatment from pharmacists that PTs and PAs experience, which has been linked to the creation 
of in-groups and out-groups (Graen & Uhl-Bien, 1995) and resulted in staff feeling undervalued 
as noted in employee surveys (Organization X, 2016b, 2017b).   
Additionally, there are several technological factors that need to be examined. For 
example, outdated SOPs and workflows do not adequately reflect the new operational reality of 
the pharmacies. The IT systems that are currently being used are also important to the daily 
functioning of the pharmacy and would be impacted by any workflow changes proposed by the 
OIP. It is also essential to consider the fast-paced and task-oriented nature of the work 
environment which has contributed to issues related to task delegation on the part of pharmacists, 
such as not delegating technical tasks to PTs, or delegating tasks to PAs when they should not be 
doing so. 
When considering the inputs of a system, one must not overlook the importance of 
culture. While my OIP does not explore the role of organization culture in depth, in the context 
of this analysis, organizational culture encompasses various elements such as ParentCorp’s 
values that the organization is expected to embody and reflect (ParentCorp, 2018b) as well as the 
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values that my organization espouses which were elaborated on in chapter one, and which centre 
around the strong belief in community engagement and providing equal care and access to 
patients from all socio-economic backgrounds (Nasra, 2018a). Another contributor to 
organizational culture stems from the profession itself. Pharmacy is an ancient profession with 
deep religious and spiritual roots that to this day can be seen in the various symbols that 
represent it (e.g., the bowl and serpent-wrapped staff). Priests and men of religion across the 
centuries concocted remedies from plants, natural minerals and animal products to heal ailments 
(Kremers & Sonnedecker, 1986). Today, more and more practitioners are recognizing that the 
future of pharmacy lies not in the disease-centered model that was promoted by the scientific 
revolution, but in a patient-centric approach that treats body, mind and spirit (de Oliveira & 
Shoemaker, 2006), which is in-line with my organization’s values and my personal beliefs as a 
leader. Although culture is not explicitly addressed in my OIP, its influence permeates all its 
aspects, from the actual problem of practice which seeks to address ethical concerns impacting 
patient safety to the leadership approach that emphasizes the relational aspects of leader-follower 
interactions. 
Strategy. The organization’s strategy, simply stated, centres around serving community 
healthcare needs in a safe and effective manner, while also generating profit and fulfilling 
responsibilities to shareholders and ParentCorp. Given the problem of practice, there currently 
exist gaps in performance that prevent the espoused strategy from being implemented effectively 
which is symptomatic of an incongruence between one or more components of the organization’s 
transformational process and/or its inputs (Nadler & Tushman, 1980; Seong, Kim, & Szulanski, 
2015). A gap between the way an organization operates (i.e., theories-in-use) and the way it 
claims to operate (i.e., espoused theories) is highly problematic and should be addressed (Argyris 
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& Schön, 1974; Beer & Nohria, 2000). In chapter one, the current organizational gaps that I 
highlighted revolved around the organization’s performance, specifically as it pertains to 
increasing dispensing error rates and declining employee engagement and patient satisfaction. 
The OIP’s proposed solutions and implementation plan, which will be discussed in detail in later 
sections of this chapter and in chapter three are geared towards addressing these gaps and 
moving the organization towards its desired optimal state (Bolman & Deal, 2013; Cawsey et al., 
2016). 
Formal organization. The formal organization according to the Congruence Model 
includes “the range of structures, processes, methods, procedures and so forth that are explicitly 
and formally developed to get individuals to perform tasks consistent with organizational 
strategy” (Nadler & Tushman, 1980, p. 44). In my context, these include a variety of systems and 
tools that are used to manage tasks and ensure compliance such as SOPs, regulations, and 
standards set by governing bodies (e.g., OCP), IT systems and procedures managed by 
ParentCorp, as well as the workflows that are adapted to all of the abovementioned “controls” 
and designed to facilitate task performance efficiently. Error reporting mechanisms are also part 
of the formal organizational arrangements but are considered to be external to the system and 
therefore will not be explicitly addressed in this analysis or the OIP.  
Informal organization. According to Tushman and Nadler (1992), the informal 
organization develops over time and encompass “the structures and procedures that emerge while 
the organization is operating” (p. 51). These arrangements are typically “implicit and unwritten, 
but they influence a good deal of behavior” (Nadler & Tushman, 1980, p. 44). In my OIP’s 
context, the informal organization would include the routines that developed over time between 
pharmacists and support staff as they worked together. The deviation of these informal 
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arrangements from formal organizational structures represents serious concerns that contribute to 
the problem of practice such as the delegation of tasks to PAs out of convenience, or not utilizing 
PTs technical expertise in order to avoid disruption of pharmacists’ work habits (Nasra, 2018a).  
People. While the organization employs a wide-range of employees to manage front-
store operations, for the purposes of the OIP, only individuals involved in pharmacy operations 
will be included in the analysis. The most senior individual is the Chief Pharmacist who is also a 
co-owner/partner in the organization. The Chief Pharmacist is the individual who directly 
interacts with governing bodies and insurance companies over contractual matters and reporting 
requirements. The organization also employs pharmacists, and PTs and PAs as support staff. As 
detailed in chapter one, each shift includes a pharmacist who is paired with one or more support 
staff members (PT or PA). The pharmacist on-shift is the de-facto leader, and all aspects of 
pharmacy operational decisions rest with him/her, with the Chief Pharmacist only contacted in 
exceptional circumstances that require intervention or additional assistance. When dispensing 
errors occur, it is the pharmacist who signed off on the prescription in question that is involved in 
reporting the incident to the OCP. The Chief Pharmacist, however, is advised and involved in the 
review process. The pharmacy team also engages with the CHRO (myself) who is responsible 
for recruitment, training design, performance reviews, and workflow design and optimization. 
All these tasks are carried out in conjunction with the Chief Pharmacist. Beyond the 
identification of the different roles in the pharmacy, Tushman and Nadler (1992) emphasized the 
importance of “identifying the characteristics of the employees or members … individual 
knowledge and skills, the different needs or preferences of individuals, and the perceptions or 
expectations that they develop” (p. 49). These issues will be considered in more detail in chapter 
three, as they are fundamental to the successful implementation of the change plan.  
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Work/Task. The main functions of the pharmacy are the dispensing of prescribed 
medications and the delivery of clinical services within the scope of practice (Abramowitz, 2009; 
Remington, 2006). Chapter one described at a high-level the tasks that comprise these two 
functions and who is allowed to carry them out as per OCP regulations and internal policies. 
Table 3 below provides a detailed break-down of the tasks that comprise a pharmacy’s workflow 
and the pharmacy member who is permitted to perform them.  
Table 3 
 
Pharmacy Workflow Tasks 
Task  
(Staff member 







Task involves receiving prescription from patient, entering the details in the 
IT system, and placing the prescription in the filling queue based on agreed-
upon delivery time. This step also includes confirming whether there are any 
changes to the patient profile and making those changes accordingly. Once 
the data is entered in the system, it is automatically adjudicated (sent to 





Task involves retrieving prescription bottles from shelf (or materials for 
pharmacist to prepare a product such as creams etc.), measuring the required 
quantity (e.g., counting), placing the drugs in appropriate packaging (e.g., 
vial), printing the labels utilizing the IT system, and placing the hardcopy of 
the prescription, medication bottles used for filling, and vials along with all 




Prescription checking is made up of 3 subtasks, Data Verification (DV), 
Clinical Verification (CV), and Product Check (PC). 
 
 DV Data verification involves confirming that the information entered 
in the IT system matches the prescription (i.e., the technical 
aspects of the prescription). 
 
 CV Clinical verification involves reviewing the clinical 
appropriateness of a prescription (e.g., drug interactions) by 
referring to patient profile in IT system. 
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Table 3 (continued). 
 PC Product checking confirms that a prescription has been filled 
correctly (by comparing bottles used for filling against 
prescription and verifying the contents of vial). This step also 
confirms that the labels on the vials match the items that have 





This task involves looking up the patient profile and determining the status of 
their prescription at the designated pick up area. Prescriptions are then 
reconciled in the IT system (i.e. scanned to denote delivery) and provided to 
the patient. If any notes have been included with the prescription, they are 
provided to the patient. If patient counseling is required, the prescription is 





This task involves providing the patient with any information regarding the 
prescription that is being picked up and answering any questions the patient 
may have. If follow-up is necessary, the request is logged in the IT system.  
 
Note. Adapted from ParentCorp Playbook: Roles & Responsibilities. 
 
As can be noted from the table, all the tasks can be completed by the pharmacist, which 
by design creates substantial role overlap. This is in part due to the fact that the pharmacist 
should be able to independently operate the pharmacy in the absence of support staff. There is 
also significant overlap between PT and PA tasks. It is important to note that this division is a 
representation of what is legally allowed per legislative and policy guidance. Workflows in the 
pharmacy can be designed in a way that limits the tasks that each member undertakes even if 
their scope permits them in order to maximize efficiency and optimize performance. A challenge 
for this OIP is therefore to delineate the various tasks that each team member can perform and 
attempt to reorganize them in a manner that addresses the concerns that were raised in the 
problem of practice. This will be addressed in detail in the proposed solutions section that 
follows. 
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Outputs. Tushman and Nadler (1992) highlight that in systems and organizations “the 
critical question is not what are the components, but what is the nature of their interaction and 
how do the relationships among the components affect how they combine to produce output” (p. 
51). Viewed from this a macro/system level perspective, the pharmacies’ outputs at a 
foundational level are the delivery of healthcare products and services and the revenue that is 
generated from operations. At the meso/unit level, the outputs of the system revolve around the 
functioning of the pharmacy teams. This would include each shift (team) working efficiently and 
effectively to fill prescriptions and dispense clinical services to patients on time and without 
incident. An important output that is related to the team’s tasks is ensuring that each shift clears 
all the prescription queues on time to prevent handing over a backlog to the following shift, as 
this would be one area where the output directly impacts the performance of tasks (feedback). At 
the micro/individual level, the system’s outputs can be summarized into two broad categories, 
employee engagement and satisfaction and patient satisfaction. 
Fit Analysis  
Analysing the different components of the organization reveals important tensions and 
areas where there is a lack of fit/congruence. First, the outdated SOPs and workflows have a 
direct negative impact on the performance of tasks for all the employees. This represents a key 
area that needs to be addressed by the OIP’s proposed solutions. Second, the routines and work 
habits that have developed over time (informal organization) also do not align properly with the 
tasks. When pharmacists delegate technical tasks to PAs, this poses a high risk to patient safety, 
in addition to being in direct contradiction with OCP regulations (formal organization). Failing to 
properly make use of PTs’ skills also has detrimental impacts that range from suboptimal 
pharmacy performance to low employee engagement and morale. As such, the proposed 
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solutions which will be explored in the following section will focus on these areas where there is 
a lack of fit between the organization’s formal and informal processes and employee tasks, as 
they prevent the organization from successfully pursuing its goals and strategy (Nadler & 
Tushman, 1980).  
While the Congruence Model analysis has provided crucial insights, there is an additional 
component that is critical to the problem of practice that has not been tackled that relates to 
patient perceptions of pharmacy support staff, which was discussed in chapter one. While patient 
satisfaction is an important output of the system, customer satisfaction surveys have revealed a 
over the last two years, PAs received 32% more complaints than PTs, often noting a lack of 
willingness to help or assist with patient queries (Organization X, 2016b, 2017b). The surveys 
also reveal that one of the main reasons behind this discrepancy is the inability of patients to 
differentiate between various members of the support staff, and an expectation that they are all 
equally knowledgeable. This issue impacts both patient and employee satisfaction levels and is 
therefore pertinent to this OIP.  
The areas of concern and incongruence (lack of fit) that were uncovered and underscored 
by the critical organizational analysis are at the foundation of the problem of practice, and by 
extension represent the main focus that the proposed OIP solutions should attempt to address in 
the following section. 
Possible Solutions to Address the Problem of Practice 
The critical organizational analysis shed light on key areas of misalignment within the 
organization, which when coupled with the contextual background and priorities for change 
discussed in chapter one, can inform several possible solutions for the problem of practice. 
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Accordingly, three mains solutions are being advanced in this section that tackle the following 
focuses stemming from the analysis:  
- Suboptimal performance and safety concerns related to outdated workflows. This focus is 
directly related to pharmacy staff's ability to provide products (prescription filling) and 
services (clinical services) in a safe manner that complies with regulations and policies. 
- Employee engagement and morale. This topic is tied to the observed decline in employee 
engagement and satisfaction surveys (Organization X, 2016b, 2017b). 
- Patient satisfaction and perceptions related to pharmacy support staff. This is linked to 
the increased level of complaints lodged against PAs (Organization X, 2016a, 2017a).  
Solution One: Modify Pharmacy Hiring Practices/Pharmacy Support Staff Composition 
As outlined in chapter one, the symptoms of the problem of practice are linked to the 
expansion of the scope of practice for pharmacists and the subsequent introduction of the PT role 
(OCP, 2012; OPA, 2014). During each shift, pharmacists and support staff work in close 
conjunction in the performance of their tasks (Nasra, 2018a). Given that many of the issues that 
are being experienced are related to interactions between pharmacy staff members, one possible 
solution that could be implemented is for the organization to employ only PTs or PAs as support 
staff. Doing so would eliminate the issue of differential treatment that is currently experienced 
by PTs and PAs, and the creation of in-groups and out-groups (Erdogan & Bauer, 2014; Graen & 
Uhl-Bien, 1995), which has been linked to lower employee satisfaction and morale (Inoue et al., 
2016).  
Hiring PTs. Given that the PT role was introduced to alleviate the increased workload on 
pharmacists (Frost & Adams, 2017; Koehler & Brown, 2017; Lynas, 2011), hiring PTs 
exclusively may seem like an optimal choice. There is some support in the literature for this 
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option. Studies suggest that pharmacists exhibit a more pronounced sense of trust and respect for 
PTs than they do PAs (Bullock et al., 2016), and that they view their relationship with PTs as 
more collaborative whereas their relationship with PAs is described as more supervisory 
(Bullock et al., 2016). Despite valuing PTs more, research findings however also indicate that 
pharmacists do not delegate technical tasks to them (Schafheutle et al., 2008), which could be the 
result of tensions due to role overlap (Gregory & Austin, 2017; Grindrod et al., 2013) and a 
reluctance to give up tasks that have traditionally been associated with their authorities (Pojskic, 
MacKeigan, Boon, & Austin, 2014). In other words, dissociating the technical aspects of 
prescription filling from the traditional pharmacist workflow has not proven to be simple, as it 
can be perceived as a threat to one’s professional identity (Gregory & Austin, 2017). One 
important thing to consider however is that an all-PT support staff option means that PTs would 
be required to take on all the clerical aspects of pharmacy work previously performed by PAs 
(e.g., filing, data entry), which would reduce their ability to assist pharmacists and could have a 
negative effect on their engagement and morale (Inoue et al., 2016).  
 Hiring PAs. The other alternative for this solution would be to exclusively rely on PAs 
as support staff. Interestingly, recent studies have found that the majority of pharmacies looking 
to hire support staff, tend to hire PAs more disproportionally than PTs (Bullock et al., 2016). 
While this option may be appealing given that hiring PAs does create consistency in terms of 
who the pharmacist interacts with and can simplify workflows, this does little to alleviate the 
increased workload on pharmacists and is therefore not a viable option for the OIP. 
Resources. Each pharmacy currently employs four support staff, one PT and three PAs. 
The major concern that this option poses relates to cost. In 2018, the starting rate for a PA was 
$14, whereas the starting hourly wage for a PT was $22.30, with each full-time support staff 
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member works an average of 35 hours a week (ParentCorp, 2018c). Hiring PTs exclusively 
would result in an estimated increase of $45,300 annually at a minimum in personnel costs per 
pharmacy which is untenable. Hiring decisions in the organization as they relate to costs are 
influenced by their impact on profitability metrics that are set and monitored by ParentCorp. One 
key performance indicator that ParentCorp sets is the wage-cost-per-script (WCPS). The WCPS 
is based on a calculation that considers the average labour costs involved in filling a single 
prescription and varies from one pharmacy to another1. The lower the WCPS, the more profitable 
the pharmacy is considered (Nasra, 2018a). Switching from a mixed support staff cadre to one 
that is exclusively comprised of PTs would significantly increase the WCPS and be considered 
detrimental to the financial performance of the organization. Given that there is no legislative 
(structural) imperative for a pharmacy to hire PTs, it would be extremely difficult to justify this 
solution to shareholders and ParentCorp. 
 From a senior (and personal) leadership perspective, this solution poses several concerns. 
First, and as highlighted above, the increased costs involved in hiring only PTs makes that option 
unappealing. Even though I am the CHRO and a partner in the organization, it would be difficult 
to justify the costs that would be incurred to the other partner, shareholders and to ParentCorp. 
Moreover, having PTs expend time and effort completing clerical tasks that they would need to 
take on should they be the only support staff in the organization does not represent an efficient 
use of organizational resources, making the financial calculus of this option even less desirable. 
Alternatively hiring PAs exclusively does not permit the organization to meet the needs of 
patients or pharmacists who will continue to experience strain as they struggle to be solely 
 
1 WCPS is dependent on variables such as pharmacy sales growth, volume of prescriptions and the age of the 
pharmacy.  
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responsible for both prescription filling and providing clinical services. Viewed from a neoliberal 
lens, the option of hiring one type of support staff, whether PA or PT, does not represent a good 
way forward for the organization, as it renders it less competitive, less efficient and unable to 
effectively regulate its operations in the current environment (Davies, 2014b; Harvey, 2005). 
Solution Two: Public Information/Education Initiative 
Despite the provision of clinical services in community pharmacies, little research has 
been conducted to empirically investigate patient perceptions of these initiatives (Latif, 
Boardman, & Pollock, 2013). One aspect of organizational performance that this OIP seeks to 
address is patient satisfaction. While operationalized through customer satisfaction survey 
ratings, patient engagement has the potential to affect other aspects of the problem of practice, 
most notably through the facilitation of the delivery of clinical services. As such, one possible 
solution that warrants examination is the implementation of a patient education campaign or 
efforts whose aims would be to inform the public as to the different roles of pharmacy team 
members as well as the availability and benefits of pharmacy-based clinical services. In addition 
to improving pharmacy performance through the increased delivery of clinical services, a key 
symptom this intervention seeks to address are patient complaints about support staff inability to 
provide healthcare advice (Organization X, 2016a, 2017a).  
Pharmacists are in the unique position of being the most accessible healthcare providers 
in communities. As such attempts to expand their role in patient education programs has been the 
subject of study over the last few decades, as the shift towards patient-centered care continues to 
grow (Babb & Babb, 2003; Rupp, DeYoung, & Schondelmeyer, 1992). Studies have 
demonstrated the positive impact of pharmacy-based patient education in the management of 
diseases such as asthma (McLean, Gillis, & Waller, 2003), cholesterol-level management 
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(Tsuyuki et al., 2002; Tsuyuki, Olson, Dubyk, Schindel, & Johnson, 2004), diabetes (Mansell & 
Perepelkin, 2011), and cardiovascular disease (Warden, Freels, Furuno, & Mackay, 2014) among 
other conditions. Moreover, studies that have explored the impact of education on patient 
satisfaction on pharmacy-provided services (e.g., medication management) have reported 
positive results (Kim, Martin, Pierce, & Zueger, 2016; McGivney et al., 2007; Naik Panvelkar, 
Saini, & Armour, 2009).  
Resources. Studies have shown that in order to change public perceptions about the role 
of pharmacists’ in communities, appropriate marketing methods are needed (McDonough, 
Pithan, Doucette, & Brownlee, 1998). Promoting a product is fundamentally different than 
promoting a health service, which requires building the confidence and knowledge of physicians, 
patients, and other stakeholders regarding the benefits of such a fundamental change in 
community pharmacy practice (McDonough et al., 1998; Perepelkin & Dobson, 2009). As such, 
the main resources that are required for this solution would be the development of a tailored 
educational and marketing plan that is aimed at providing the public with a clear understanding 
of the role of all pharmacy staff. Educating the public as to the role of pharmacists should also 
highlight the limitations of what support staff can do, which can go a far way in managing 
patient expectations. In addition to improving the delivery of clinical services, this education 
campaign can also change patient perceptions and skepticism that pharmacists may be providing 
these services to simply improve their bottom-line (Guirguis et al., 2014). The costs of this 
solution can vary greatly depending on the type of campaign that is undertaken which can be 
limited to pharmacy staff time dedicated to patient education or can include the provision of 
educational marketing materials (e.g., printing pamphlets and posters). This solution would 
require a comprehensive cost analysis; however, it is fair to expect that the increase in revenue 
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generated from the provision of additional clinical services would likely offset a portion of these 




Clinical Services Reimbursement Schedule 
Program Payment 
MedsCheck – Annual $60 
MedsCheck – Follow-up 
• Hospital discharge 
• Physician/Nurse referral 
• Planned hospital admission 
$25 per follow-up 
MedsCheck for Long-term Care home residents  $90 annually 
$59 quarterly 
MedsCheck at home (if eligible) $150 
MedsCheck for diabetes (if eligible) $75 annually 
$25 follow-up education 
Pharmaceutical opinion $15 
Pharmacy smoking cessation program first consultation $40 
Note. Adapted from Ministry of Health and Long-term Care Professional Pharmacy 
Services Guidebook 3.0 
 
As can be noted from Table 4, the provision of clinical services effectively and efficiently 
can have a considerable financial impact on the organization’s bottom line. One of the current 
impediments to capitalizing on this revenue stream stems from the inability of the organization’s 
current work processes to effectively free-up pharmacist time so it can be dedicated to the 
provision of these services. Viewed from a neoliberal lens, clinical services represent an 
untapped market that my organization is currently unable to effectively compete in (Biebricher, 
2015; Bloom, 2017). Moreover, from a personal leadership perspective, the benefits of educating 
the public as to the roles of various pharmacy team members, as well as the availability of 
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clinical services, are extremely appealing given that they can contribute to fewer safety incidents 
as well as improved customer satisfaction and employee morale. From a neoliberal perspective, 
this solution allows the organization to better compete, by marketing clinical services to patients 
via an educational campaign, while at the same time improving pharmacy operations through the 
provision of better and safer services. As such, both from a financial and social outcomes 
perspective, the costs incurred by implementing this solution would not be difficult to justify to 
shareholders as the improvement in patient wellbeing and reduced complaints are important 
organizational outcomes. 
Solution Three: Redesigning Pharmacy Workflow 
 Workflow, defined in this OIP as the standardized process for filling prescriptions and 
delivering services, is at the core of a pharmacy’s operations and has been identified in the 
critical organizational analysis as a significant area of misalignment that needs to be addressed. 
Workflow design considers both processes as well as the physical layout and placement of 
workstations and other resources in the pharmacy (Angelo & Ferreri, 2005). Inefficiently 
designed processes and pharmacy layout have been identified in the literature as being critical 
barriers to the provision of patient counseling (Angelo & Ferreri, 2005; Lin et al., 1996) and are 
also linked to higher levels of pharmacist dissatisfaction (Lin et al., 2008). Workflow design is 
also linked to dispensing error rates (Hoxsie et al., 2006), the ability to integrate new roles in the 
pharmacy (Pai, 2005), and pharmacy performance efficiency (Cavaye et al., 2018).   
 Figure 3 below depicts the current pharmacy workflow, and its steps were described in 
detail in Table 3 of the previous section. As identified earlier, the workflow and corresponding 
SOPs have not been updated since the expansion of the scope of practice for pharmacists and the 
inclusion of PTs in pharmacy teams. Moreover, the current workflow incorporates significant 
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role overlap between all pharmacy staff, which has been the cause of tensions, and represents a 
structural obstacle contributing to the suboptimization of pharmacy performance (Bolman & 
Deal, 2013). As such, one of the possible solutions that this OIP proposes is redesigning the 
workflow to address these challenges.  
 
 The current workflow for prescription filling is made up of four distinct steps, data entry, 
filling, checking and pickup (see Table 3). As can be noted in Figure 3, any pharmacy staff 
member can perform the first two steps as well as the final step, whereas pharmacists are the 
only professionals who can complete the checking process. The current workflow suffers from 
several weaknesses: 
- In its current state, there is no step in the workflow that falls solely within the purview of 
a PT’s regulated authority. In other words, the technical aspects of filling the prescription 
are not delineated which may have contributed to the observed lack of delegation. The 
technical tasks that PTs can perform are data verification and product check which are 
currently part of the “checking” process that pharmacists perform (which also includes 
clinical verification). 
- The workflow has a high potential for the creation of backlogs or process disruptions. 
During the “checking” process, pharmacists conduct three separate sub-tasks, which take 
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up a considerable amount of time. If a pharmacist is called upon to counsel a patient or to 
deliver a clinical service (e.g., flu shot), the dispensing process cannot move forward, 
while additional prescriptions might be entered into the system and filled by support staff.  
- The data verification and clinical verification subtasks, as outlined in Table 3, require 
that a pharmacist refer to the IT system to confirm that the technical information that is 
entered in the system matches the prescription, and that there are no concerns or 
contraindications per the patient profile. Given that the prescription has already been 
filled by that stage, any errors that are identified can only be corrected by re-filling the 
prescription. Support staff would need to log the mistake, return the drugs to the bottles 
when possible, and discard the used vials and labels. Only after the mistake has been 
corrected in the IT system, can the filling process start again. In addition to being a time-
consuming process that can result in wasted products (i.e., if they cannot be returned), 
errors also trigger an inventory reconciliation process by which the pharmacist and 
support staff need to document the error and enter the quantity of drugs that was returned 
or discarded.  
Designing a new workflow would need to address many of these issues, as well as 
attempt to reduce role overlap. From an operational perspective, designing and approving a new 
workflow and the costs associated with it are within the purview and scope of authority of senior 
leadership (myself and the other partner), and as such, the implementation of this solution is a 
viable option for the OIP. Figure 4 below represents (at a high macro level) a possible proposed 
new workflow.  




In this new system, the filling process is made up of seven discrete steps. A new task, 
prescription intake, is added which allows the pharmacy team to quickly attend to patients, 
avoiding line-ups and reducing wait times when prescriptions are dropped off. At this step the 
delivery time is agreed upon, which allows the team to better manage the queue by entering the 
prescription into the appropriate time slot as opposed to the sequential entry of prescriptions in 
the system. The three sub-tasks that comprise the “checking” step (see Table 3) are divided in the 
new design, with data verification and clinical verification taking place prior to filling. The 
benefits of doing so are two-fold. First data verification can be completely delegated to PTs or 
performed by the pharmacist when only a PA is present. By performing these two tasks prior to 
the physical filling of the prescription, errors can be caught sooner and addressed, saving time 
and resources. The product check step takes place after the filling and is another task that can be 
delegated to a PT when present. The specific steps regarding how the new workflow would be 
designed will be elaborated on in the implementation plan in chapter three, (e.g., stakeholder 
consultations, changes in pharmacy systems, training) but some of the potential benefits of the 
new process include role delineation through delegation, error reduction, and increased 
efficiency.  
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Resources. Redesigning workflows is similar to reengineering or quality improvement 
techniques; it needs to be done in a systematic and methodical manner that considers multiple 
factors (Aguilar et al., 2013; Nold, 2011). The new workflow needs to identify and remove 
barriers to performance, whether they be physical or technological. Hand-offs between tasks 
need to be smooth and efficient, waste should be reduced, and redundancies and tasks that have 
the potential to create backlogs should be minimized or eliminated where possible (Nold, 2011).  
Given that this proposed solution involves process changes in the organization, the change plan 
requires an investment of financial resources and time as well as some minor modifications to 
the IT infrastructure of the pharmacy which are described below: 
- Time: Based on the timeline required for previous workflow change initiatives in the 
organization, it is estimated that the amount of time required for modifying the pharmacy 
workflow could take up to 12 months (ParentCorp, 2010). 
- Technology: Since the current IT system already contains modules for the performance of 
all the tasks in the proposed workflow, only minor changes in the permissions are 
required, to allow PTs to perform the DV and PC steps. In addition, a new computer 
terminal dedicated to PTs will need to be installed for each pharmacy, at an average cost 
of $6,000 per terminal (ParentCorp, 2018d).  
- Training: The most critical aspect of rolling out a new workflow is personnel training. 
This involves both time and financial investment (e.g., for the development of training 
materials, job aids, conducting on-the-job training). The detailed cost and description of 
the training will be explored in depth in chapter three.  
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Weighing the Options of the Three Possible Solutions 
Each of the proposed options could represent a path forward for the organization, as does 
maintaining the status quo, which can be considered a fourth option. Table 5 below evaluates 
each of the possible solutions against its ability to address the three factors identified earlier as 
being essential to this OIP. As noted earlier, modifying hiring practices is not only financially 
untenable, it only has the potential of addressing safety concerns if only PTs are hired. This 
option fails to account for the two other main factors fundamental to the problem of practice. 
Given the critical nature of the safety concerns of the problem of practice, maintaining the status 
quo is also not a viable option. Combining solutions two and three, however has the potential for 




Comparison of Proposed Solutions 
 Solution 1: Modify 
hiring practices/support 
staff composition 














Potentially No Yes No 




No No Yes No 





No Yes No No 
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In addition to addressing the major concerns of the problem of practice, both solutions 
two and three would allow my organization to better meet its obligations to both its shareholders 
and its patients. Educating the public and informing them as to the different roles of pharmacy 
team members and the services available to them and redesigning the pharmacy workflow will 
allow my organization to achieve its strategy of providing healthcare safely while remaining 
competitive (Nadler & Tushman, 1980). Adopting only one of the two solutions could lead to 
unintended consequences that might further exacerbate the gaps that currently exist. For 
example, marketing clinical services without modifying the workflow in a way that allows 
pharmacists to dedicate more time to the delivery of those services will only increase the 
pressure on pharmacists and possibly lead to additional patient complaints. In contrast, 
modifying the workflow while not educating the public as to the roles of different team members 
does nothing to address misperceptions about support staff, thereby not addressing patient 
complaints or staff morale. While it does free up pharmacist time through the delegation of 
technical tasks to PTs, workflow redesign without marketing/informing patients about clinical 
services could also introduce inefficiencies since the organization would not be making the best 
use of its human resources. Moreover, taking tasks away from pharmacists without 
counterbalancing them by creating opportunities for pharmacists to fully exercise their scope of 
practice could lead to further lowered engagement and job satisfaction (Gregory & Austin, 2017; 
Makowsky et al., 2013). Accordingly, this OIP proposes a hybrid approach that merges these two 
solutions, which allows my organization to achieve efficiencies and effectively compete in the 
new market for clinical services that was created by legislative changes (Biebricher, 2015). 
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Leadership Ethics and Organizational Change 
Ethical considerations are inherently weaved into my problem of practice and by 
extension the OIP. For instance, ethical conduct is one of the key competencies that both 
pharmacists and PTs are expected and required to demonstrate in their practice (OCP, 2012, 
2015). Organizationally, there is an expectation that all employees regardless of their 
professional background comport themselves in line with organizational values which emphasize 
ethical conduct. Moreover, the topic of ethics in healthcare continues to be a subject of great 
debate and ongoing scholarly activity (Beauchamp, 1994; Chaar, Brien, & Krass, 2005). Ethics 
also feature greatly in leadership interactions with employees and has significant implications for 
organizational outcomes. From a personal leadership perspective, addressing the ethical concerns 
that are raised in the problem of practice, and ensuring that the path forward for my organization 
aligns with my and my organization’s values is extremely important. Accordingly, this section 
will examine ethical factors as they relate to the problem of practice (organizational context), 
leadership approaches, and organization change.  
Ethical Dimensions of the Problem of Practice 
It is not surprising that ethics and pharmacy practice are deeply intertwined (Chaar et al., 
2005; Deans, 2010). From an organizational perspective, balancing a for-profit orientation with a 
social professional mission and vision can cause tensions and create opposing forces that pull the 
organization in different directions (Resnik, Ranelli, & Resnik, 2000). Pharmacies are at once 
profit-generating businesses and places that patients turn to for healing. As a result, the 
profession as a whole has attempted to impose guidelines for acceptable practices that are 
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operationalized through codes of ethics2 (OCP, 2012, 2015). Additionally, and as highlighted 
earlier, the focus of pharmacy practice has shifted over the years towards being more patient-
centric which led to the establishment of professional responsibility principles being adopted by 
the community (see Appendix) (Perepelkin & Dobson, 2009; Wingfield, Badcott, & Appelbe, 
2007).  
The ethical fundamentals that govern the practice of pharmacy are identical to other 
healthcare professions (collectively referred to as bioethics) and include: “beneficence (the moral 
obligation to benefit others); non-maleficence (to do no harm)” and “justice (fair, equitable and 
appropriate treatment)” (Beauchamp, 1994; Beauchamp & Childress, 2001; Char et al., 2005, p. 
196). As indicated in chapter one, my organization is committed to serving patients regardless of 
their socioeconomic background and is frequently engaged in community outreach. Those are 
the key values that the organization strives to adhere to, to the best of its ability, while still 
maintaining fiduciary responsibility and accountability to its shareholders. However, some of the 
symptoms of my problem of practice, most notably the performance of certain tasks by non-
regulated support staff and the incidents where PAs have dispensed medical advice to patients, 
not only represent serious ethical breaches, but also have the potential to cause serious harm. 
While these incidents are not unique to my organization (Haddad, 1991; Hibbert, Rees, & Smith, 
2000), this OIP needs to address these issues head-on to ensure the proper alignment of tasks 
with strategy (Nadler & Tushman, 1980) and that the changes that are implemented prevent these 
incidents from reoccurring. Moreover, addressing these ethical concerns represent a priority for 
 
2 The OCP code of ethics is available from 
http://www.ocpinfo.com/library/council/download/CodeofEthics2015.pdf 
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myself as a leader in the organization who strongly believes in the importance of taking 
responsibility and modeling the behaviours I expect from my employees. 
Ethics in Leadership  
Ciulla (2012) noted that just because someone holds a position of power does not 
necessarily mean that that individual is an effective leader, especially if they fail to meet the 
ethical characteristics that are expected of them. As indicated earlier, the fast-paced and task-
oriented nature of pharmacy practice precipitated a dominant transactional leadership style 
(Avolio & Bass, 2002; Judge & Piccolo, 2004). Moreover, the differentiated nature of the 
exchanges between pharmacists and support staff have impacted the quality of the relationships 
between leaders and followers (Day & Miscenko, 2015; Erdogan & Bauer, 2014). According to 
Groves and LaRocca (2011), transactional leadership is grounded in “teleological ethical 
values”, also referred to as utilitarianism (p. 511). From this perspective, ethics are limited to 
“whether what is being done (the end) and the means employed to do it are morally legitimate” 
(Bass & Steidlmeier, 1999, p. 185). It is important to highlight that transactional leadership is not 
inherently harmful to followers, rather it is founded on an individualistic view where both leader 
and follower are governed by their pursuit of self-interest (Bass & Steidlmeier, 1999). While 
leadership that focuses on outcomes and compliance (Groves & LaRocca, 2011) is beneficial in a 
highly regulated, task-driven environment, such a view is not conducive to employee 
engagement and motivation that are essential to the change process (Kotter, 2012). In other 
words, leadership that is based on structured exchanges is not enough, it is equally important to 
consider the relational aspects of work-based interactions.  
Scholars have only recently begun examining LMX and ethical dimensions of leadership 
(Mahsud et al., 2010). The relationship between LMX quality and a plethora of follower 
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outcomes with ethical implications, such as commitment and counterproductive work 
behaviours, have been studied extensively with a general consensus that high LMX quality is 
associated with positive outcomes and vice versa (e.g., Gerstner & Day, 1997; Martin et al., 
2016). Given that LMX quality is directly linked to the differentiated nature of leader-follower 
exchanges, it is important to consider how factors that inhibit LMX quality in the organization, 
such as pharmacists engaging with and displaying more trust in PTs than PAs, could have 
contributed to the symptoms of the problem of practice which are ethically problematic. While 
there are indications that PAs who have dispensed medical advice to patients did so to avoid 
complaints, it is also possible that their actions were motivated by a desire to improve the quality 
of their relationship with the pharmacists by demonstrating competence or attempting to replicate 
PT behaviours that they associate with higher LMX quality. It is for this reason that a structured 
relational approach to leadership that considers both the transactional and interpersonal aspects 
of the leader-follower relationship is appropriate for the organization and the OIP (see Figure 1). 
This approach also enables me as a leader to focus organizational resources towards the very 
important tasks of relationship and trust-building that are at the core of my leadership style and 
philosophy, and to leverage my leadership to achieve the desired organizational outcomes. 
Ethics and Organizational Change 
The process of implementing organizational change is by definition rife with shifting and 
complex dynamics that employ change agents and drivers to steer the organization in the desired 
direction (Burnes, 2009; Weick & Quinn, 1999). The framework for change utilized in this OIP 
(Kotter, 2012) is part of a larger shift in the change literature described as “emergent” 
approaches (Caldwell, 2006; Kanter, Stein, & Jick, 1992). Emergent organizational change is a 
“complex and incremental process of shaping how change unfolds over time” (Caldwell, 2006, p. 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 80  
 
 
77). Ethical concerns as they pertain to emergent approaches to organizational change stem from 
their emphasis on the role of power, politics, and influence (Burnes, 2009). A focus on achieving 
outcomes and generating momentum, if not considered carefully, can easily overlook how 
organizational members are impacted by change. While emergent approaches to change are, by 
design, holistic and contextual (Mintzberg & Westley, 1992), issues of ethics are not always 
explicitly considered (Burnes, 2009).  
In describing the framework for change earlier in this chapter, I emphasized the 
importance of inclusion and the engagement of all organizational members to generate buy-in 
and maintain momentum (Kotter, 2012). Equally important from an ethical perspective is an 
emphasis on generating consensus and empowering employees and creating a participative 
environment (Wooten & White, 1999). As such, employee engagement and active involvement 
in the implementation of the change initiative is a cornerstone of the plan that I detail in chapter 
three. Change should not be imposed on organizational members, rather through open 
communication, collaboration, and transparency, employee voices can and should be heard 
throughout the initiative. While the premise of the OIP is the improvement of organizational 
performance, leadership’s role in influencing and shaping change should not supersede the needs 
of employees. This is especially important given the power differential that exist between 
pharmacy team members. Whether intentional or not, PAs do not possess the same amount of 
influence as PTs do, and as such, it is imperative that their concerns be heard, and their input 
solicited at every stage. It is for this reason that I as a leader have taken the change process itself 
as an opportunity to address employee equality by ensuring that PAs’ needs and roles are 
emphasized and highlighted in the organization, so that they understand that their contributions 
are vital and critical to the organization’s functioning. Doing so in a thoughtful and proactive 
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manner will also go a far way in generating organizational change that is enduring (Wooten & 
White, 1999).   
Ethics and Neoliberalism 
As indicated earlier, this OIP has, for the most part, approached the problem of practice 
from a neoliberal perspective. At first glance, addressing ethics and its importance in my 
organization may seem paradoxical when viewed from a neoliberal lens. Indeed, the issue of 
moral responsibility and ethics in neoliberal thought has become a topic of interest for scholars 
(cf. Bloom, 2017; Davies, 2014a), especially post the 2008 economic crisis that was blamed in 
large part on neoliberal policies that deregulated financial markets (Bloom, 2017). Scholars posit 
that far from being a hyper-capitalist, greed-driven philosophy, neoliberal thought and principles 
are responsible for the emergence of “business ethics” and “corporate social responsibility” as a 
means of self-regulating (Shamir, 2004). Viewed from this perspective, codes of conduct and 
organizational values are tools that corporations use to regulate themselves “in order to act 
legally in their pursuit of profit” (Bloom, 2017, p. 11).  
One of the renowned scholars in neoliberalism, William Davies, in his seminal work The 
Limits of Neoliberalism suggests that the universal drive for competition that was championed by 
neoliberal thought was not structured entirely by the desire to achieve efficiency and increase 
productivity, but also by the intrinsic human need for achieving happiness and promoting well-
being (Davies, 2014b). In other words, satisfaction, happiness and well-being are as much goals 
of a neoliberal society as is profit (Davies, 2015). While a full exploration of this new stream of 
academic work is beyond the scope of this OIP, my main thesis is that ensuring that patient and 
employee well-being and satisfaction are being addressed is not antithetical to a neoliberal 
perspective. To the contrary, pursuing these goals, which are at the foundation of my leadership 
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philosophy, I believe, will yield positive outcomes to my organization and the communities it 
serves and are in line with the approach to change which I have taken in this OIP.   
Chapter Summary 
 Chapter two highlighted the potential that adopting a Structured Relational Leadership 
approach has in supporting this OIP. Kotter’s (2012) Organizational Change Framework was 
used to provide a phased process for introducing, implementing, and sustaining change in the 
organization. A critical organizational analysis utilizing Nadler and Tushman’s (1980) 
Congruence Model revealed areas of misalignment and lack of fit in the organization that 
corresponded to the symptoms of the problem of practice and that were used to put forth possible 
solutions. Finally, I highlighted the ethical implications of the OIP as they pertain to the 
organizational context, the leadership approach, and the change initiative. Chapter three will 
delve into the details of the change initiative and will introduce Deming’s (1994) PDSA cycle as 
the foundation for the implementation of the change plan.  
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Chapter 3: Implementation, Evaluation and Communication 
While chapter two provided an in-depth analysis of the organization and put forward 
proposed solutions for change, chapter three’s overall objective is to chart out a detailed path 
forward for the organization towards the attainment of the desired future state. Accordingly, 
chapter three comprises three distinct, but complementary and connected components: the 
change implementation plan; a change process monitoring and evaluation strategy; and a plan to 
communicate the need for change and the change process. While each topic will be addressed in-
depth in its respective section, all three aspects of the change initiative are intrinsically linked 
and will unfold simultaneously building on and feeding into each other.  
Change Implementation Plan 
In order to properly tackle the concerns outlined in the problem of practice, the OIP will 
focus on the two main solutions that were proposed in chapter two: the development and 
implementation of a patient-focused education initiative and redesigning the pharmacy 
workflow. These two solutions were selected because together they address the following 
overarching dimensions of the problem of practice and the OIP: safety concerns; employee 
engagement and morale; patient satisfaction and perceptions relating to pharmacy staff; and 
suboptimal organizational performance. 
Evaluating each of the proposed solutions in chapter two revealed that no single approach 
could address all the above dimensions. Given the interconnected nature of the problem of 
practice’s symptoms, as described in chapter one, a comprehensive approach is therefore 
necessary in order to anchor and institutionalize change within the organization and to maximize 
the chances of success (Cawsey et al., 2016; Kotter, 2007, 2012). The implementation plan for 
the two solutions will be guided by Kotter’s (2012) change framework, which was described in 
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detail in chapter two. The details and steps involved in the implementation of the two solutions 
will be discussed in detail below.  
Selecting the Change Agents 
For each of the solutions, a guiding coalition will be created to lead the implementation 
(Cawsey et al., 2016; Kotter, 2012).  In addition to being in line with the OIP’s change 
framework, this approach was chosen because it ensures that stakeholders from various levels 
and groups in the organization are represented and consulted which can contribute positively to 
engagement and buy-in, and facilitate communication (Calegari et al., 2015; Hoadly & Lamos, 
2012). Each team will be comprised of the Chief Pharmacist, the CHRO and representatives 
from the pharmacist and support staff cadres (PT and PA). One of the reasons that two separate 
teams (one for each solution) are needed is to not overload employees who, in addition to being a 
part of the guiding coalition, still need to carry out their functional duties (Bliese & Castro, 2000; 
Quinn, 1988; Vakola & Nikolaou, 2005). Given that senior leadership in the organization will 
have to be involved in both guiding coalitions, it is for this same reason that one concern that 
needs to be monitored closely is senior leadership’s ability to contribute effectively to both 
solutions while carrying out their regular duties. Mitigating this concern will be discussed in the 
limitations section of this chapter.  Given the nature of the changes, there is no expectation that 
ParentCorp will participate in either guiding coalition since it does not play a direct role in the 
daily operations of the organization and its permission is not required to approve or enact the 
proposed changes. In describing the implementation of both solutions below, I ensured that the 
actionability and timeliness of the plan was highlighted by identifying short, medium and long-
term goals and steps (Bolman & Deal, 2013; Cawsey et al., 2016). Given that the organization is 
owned by two partners (myself and the Chief Pharmacist), an underlying assumption of the 
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implementation plan is that the costs that would be incurred will be approved and authorized. 
With an average operational cost (wages and expenses) of $2.5 million dollars annually per 
pharmacy (Organization X, 2017c), the cost of implementing both solutions could be considered 
part of the regular operational expenses3.  
Solution One: Patient Education Initiative  
The main goal for this solution is to develop a comprehensive educational initiative 
aimed at providing the public with accurate information regarding pharmacy member roles and 
pharmacy-based clinical services that are available to them. One key objective for this part of the 
plan is to improve patient safety through the reduction of incidents where support staff members 
provide unqualified medical advice (Nasra, 2018a; Organization X, 2016a, 2017a). By clearly 
defining support staff roles and educating the public, two additional related objectives for this 
solution are improving patient satisfaction and perceptions of support staff as well as employee 
morale and engagement. 
Table 6 below outlines the steps involved in the implementation of the patient education 
initiative as well as a breakdown of the resources and the timeline required for implementation. 







3 While annual budgets are set by Organization X, the franchise-ownership model allows owners/partners discretion 
over operational expenditures (e.g., overtime wages, purchase of materials, training etc.) 




Solution One Implementation Details 
Implementation Process/Steps Resources Timeline 
1. Develop educational material 
to highlight pharmacy team 
member roles. 
Design and produce 
signage/posters for pharmacy. 
Design and produce pamphlets 
for patient distribution. 
Cost: Variable but minimal 
given availability of printing 
resources within pharmacy. 
 
Short-term: 1-2 months 
2. Obtain educational material 
describing expanded scope of 
practice for pharmacists from 
Ministry of Health and Long-
Term Care.  
2a. Obtain permission to use 
educational material or 
modify internally. 
Materials from Ministry of 
Health & Long-Term Care. 
Produce printed pamphlets for 
patient distribution. 
Cost: variable but minimal given 
availability of printing resources 
within pharmacy. 
Short-term: 1-2 months 
3. Decide on changes to support 
staff uniforms. 
Order new uniforms from 
supplier. 
Produce pharmacy signage 
explaining the changes. 
Cost: Normal part of operational 
costs since uniforms are ordered 
on regular basis. Minimal cost to 
printing signage given 
availability of printing resources 
in pharmacy. 
 
Short-term: 3-5 months 
4. Develop schedule for “clinic 
days” for specific interventions 
and clinical services (e.g., 
diabetes, hypertension). 
Additional staff required for 
clinic days. 
Cost: Variable depending on 
number of hours. Wage 
estimates are: 
- Pharmacist: $45-$55/hr 
- PT: $22-$26/hr 
- PA: $14-$25/hr 
Mid-term: 3-5 months 
5. Change roll-out: 
5a. Distribute educational 
materials 
5b. Schedule clinic days 
5c. Implement new uniforms 
 
 Long-term: 6 months - ongoing 
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Short-term. During the first two months, the guiding coalition’s main activities will be 
focused on the development of educational materials for patients. First, the team will produce 
informational material explaining the roles and responsibilities of each pharmacy team member. 
The content will be developed by referring to formal documentation from the OCP (OCP, 2012, 
2015), the National Association of Pharmacy Regulatory Authorities (NAPRA, 2014), and 
internal organizational documentation (ParentCorp, 2015). The guiding coalition will also solicit 
input from organizational members regarding changes that will be made to pharmacy team 
uniforms so that patients can easily distinguish between team members. Additionally, 
educational material regarding the expanded scope of practice/clinical services that are available 
to patients will be obtained from the Ministry of Health & Long-Term Care in both official 
languages to inform patients about the range and the benefits of pharmacy-based clinical services 
that are available to them (Ministry of Health & Long-Term Care, 2016). Once the materials 
have been obtained and tailored to organizational needs, they will be printed internally, as is 
done regularly for other signage and educational material, and the new uniforms will be 
procured. The educational material will be provided to patients in either official language, since 
patient preference is logged in the patient profile. 
Mid-term. The next task that guiding coalition will undertake is related to developing a 
sustainable and efficient approach for the delivery of clinical services in the pharmacy. This will 
involve the scheduling of “clinic days” during which dedicated staff will be available to 
administer clinical services to patients, as well as provide educational resources related to the 
management of chronic diseases such as diabetes and hypertension. This task is critical to the 
success of the educational initiative as it allows patients to book appointments with pharmacists 
and know beforehand when dedicated personnel will be available to answer their questions and 
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address their concerns. While pharmacists will continue to attend to patient needs during every 
shift, having clinic days will enable the pharmacy to better manage staff time and pharmacists’ 
workload. Research findings also indicate that interventions such as clinic days in pharmacies are 
related to better patient outcomes when it comes to managing health conditions such as diabetes 
and smoking cessation (Cranor, Bunting, & Christensen, 2003; Kennedy, Giles, Chang, Small, & 
Edwards, 2002).  
Long-term. Once the educational materials have been finalized, clinic day scheduling 
completed, and the new uniforms have been procured the next step will be incorporating the 
changes and rolling-out the initiative. It is expected that this step will take place at the six-month 
milestone and over time, the changes will become an ongoing part of the daily operations in the 
pharmacy. While an updated schedule for clinic days will be provided on a monthly basis, the 
frequency of clinic days will be modified as required by demand (which will also be addressed in 
the monitoring section of this chapter). The distribution of educational material will be rolled out 
as follows: 
• Existing patients: At the next prescription pickup, pharmacy support staff will include the 
materials with the patient’s medications and will take a few minutes to go over the 
content. Patients will also be provided a schedule of upcoming clinic days. Depending on 
a patient’s profile, relevant clinic days will be highlighted should the patient wish to 
make use of them. Patients will also be informed that counseling is available to them 
outside of clinic days should they require it. Once the information has been provided, a 
note in the patient’s profile will be made.  
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• New patients: Materials regarding pharmacy staff and available services will always be 
provided at the first transaction, after which materials will be provided in the same 
manner as existing patients.  
Understanding stakeholder reactions and managing the transition. It is important 
when introducing change within the organization to take into account how stakeholders may 
react to or perceive change (Cawsey et al., 2016). When it comes to introducing clinic days, there 
may be initial resistance from patients who may perceive that these changes are being 
implemented to augment the pharmacy’s profit (Austin et al., 2006). However, by providing 
official materials, and being transparent about the costs and the revenue generated by these 
activities, this may mitigate some of these concerns, especially by highlighting the voluntary 
nature of these services and that they are a part of a larger strategy to manage pressure on the 
healthcare system (Guirguis et al., 2014).   
Providing clinical services will require dedicated pharmacy staff time. As such, during 
scheduled clinic days, it will be necessary to have a second pharmacist on staff. By scheduling 
these days ahead of time, it will be possible to allocate resources accordingly. It can be expected 
that the revenue that will be generated through these services will help offset the labor costs 
associated with having additional staff members during each shift (Ministry of Health and Long-
Term Care, 2016). Changes in the uniform are not expected to generate resistance within the 
organization since staff will be consulted ahead of time and their input will be solicited prior to 
deciding on the final uniform choice. Ensuring broad consultation and transparency as to the 
reasons behind these changes as well as the anticipated benefits will allow employees to voice 
any concerns they may have, and for those concerns to be addressed and taken into 
consideration. Moreover, having pharmacy support staff representatives on the guiding team will 
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assist in socializing these changes in the rest of the organization and will emphasize the rationale 
for the change.  
Maintaining momentum. It is possible that after several months, pharmacy staff may 
become complacent about providing educational materials to new patients and that the 
scheduling of clinic days may not be prioritized. It is important therefore for the guiding team to 
ingrain these practices in daily activities. This can be done through incorporating these activities 
in SOPs, posting signage, and overseeing the monthly scheduling until such time that these 
activities become a part of the regular operations of the pharmacy. Incorporating feedback on 
these changes during regular performance appraisals can also help in maintaining momentum 
(Buchanan et al., 2005). 
Solution Two: Redesigning Pharmacy Workflow  
The main goal of the second solution for the OIP is to make changes to the pharmacy’s 
workflow in order to address pharmacy performance suboptimization (Bolman & Deal, 2013). In 
order to achieve that, this solution’s key objectives and priorities revolve around delineating 
tasks that PTs can perform exclusively and formalizing the role of PAs in order to reduce role 
overlap and enable proper task delegation in the pharmacy. When implemented, in addition to 
improving pharmacy performance, a properly designed workflow can also improve employee 
engagement and job satisfaction (Angelo & Ferreri, 2005; Lin, et al., 2008).  
Table 7 below outlines the steps involved in redesigning the pharmacy workflow as well 
as breakdown of the resources and the timeline required for implementation, with the details 
expanded upon and discussed in the remainder of this section. 
 
 




Solution Two Implementation Details 
Implementation Process/Steps Resources Timeline 
1. Analyze current workflow to 
identify role overlap and task 
delegation opportunities. 
 
 Short-term: 1-2 months 
2. Guiding team puts forth new 
workflow proposals for 
consultation with stakeholders; 
makes changes as required; and 
finalizes new workflow design. 
 
 Short-term: 3-4 months 
3. Prepare for new workflow 
implementation: 
3a. Map out new Information 
Technology (IT) 
requirements and processes 
3b. Develop new SOPs and 
working aids. 
3c. Develop training 
materials. 
3d. Physical modification of 
pharmacy layout (if required) 
3e. Installation of new IT 
system 
 
Training materials developed 
internally by CHRO 
Working aids, SOPs, new 
resources and references 
developed by guiding team 
New IT terminal  
Cost: $6,000 
Installation of IT terminal & 
modifying software  
Cost: variable but can range 
from $1,000-$2,000  
Physical changes to pharmacy 
layout  
Cost: variable and dependent on 
scope of changes required. 
 
Mid-term: 5-10 months 
4. Train pharmacy staff on new 
workflow. 
 
 Mid-term: 10-12 months 
5. Launch new workflow 
 
 Long-term: 12 months for 
launch 
 
Short term. The first task that the guiding coalition will undertake is to analyze the 
existing pharmacy workflow. This will be done by mapping out all the subtasks involved in the 
filling of prescriptions to pharmacy team member roles (pharmacist, PT, or PA). The analysis 
will highlight areas of overlap as well as the subtasks which can be delegated to PTs under their 
regulated authorities. The guiding coalition will then work to produce proposals for the new 
workflow design that at a high level should emphasize efficiency and quality control (Aguilar et 
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al., 2013; Angelo & Ferreri, 2005; Nold, 2011). The new workflow also needs to meet two main 
criteria: to minimize overlapping tasks and distinguish tasks that PTs can perform independently 
(Nold, 2011; Pai, 2005). The guiding team will then consult organizational members and seek 
their input on the proposal. This step is critical because ensuring buy-in for a significant change 
such as this one is essential (Cawsey et al., 2016; Kotter, 2012). Engaging with the impacted 
stakeholders also demonstrates senior leadership’s commitment to transparency and building 
trust, which are hallmarks of this OIP’s Structured Relational Leadership approach. Once 
employee feedback has been incorporated, the guiding team will finalize the new workflow.  
Mid-term. After approving the new workflow, the next step would be to prepare for its 
implementation and launch. I, as CHRO will lead the development of the training material for 
pharmacy staff on the new workflow. The guiding coalition led by the Chief Pharmacist and 
CHRO will also develop new SOPs and working aids that will replace the existing ones. The 
current IT software employed at the organization contains all the different modules that would 
encompass any workflow design. As such, no new software purchase will be necessary, however 
minor adjustments to permissions could be required to allow PTs access to specific modules. 
Additionally, a new IT terminal for PTs will be also be needed. The services of IT professionals 
will be required to make the necessary software modifications and install the new system. The 
new workflow might also necessitate some physical changes in the layout of the pharmacy which 
will need to be completed prior to launch. 
Long-term. Depending on the progress that is achieved during the mid-term goals, the 
guiding coalition will determine a hard launch date for when the new workflow implemented; but 
it is expected to be scheduled around the twelve-month mark. Once implemented, the guiding 
coalition will need to closely monitor the pharmacy’s performance as well as solicit the input of 
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pharmacy team members to make sure that the transition to the new workflow is smooth and that 
any unforeseen issues are quickly addressed. Details regarding the monitoring and evaluation of 
the implementation plan will be discussed later in this chapter, however, over time, employee 
feedback will continue to be solicited, and minor changes made to the new workflow processes to 
further improve it in order to ensure lasting long-term success.  
Managing stakeholder reactions. Changing a workflow is a complex endeavor and 
requires extensive analysis and planning (Angelo & Ferreri, 2005). There are several possible 
implementation issues that may arise, chief among them is resistance to change. One of the 
outcomes of the new workflow is the formalization of the pharmacist-PT delegation process 
which entails pharmacists giving up some of their current authorities so that PTs take on new 
responsibilities. Research has shown that individuals don’t usually respond positively to giving 
up “power” (Pojskic et al., 2014). Having a pharmacist representative in the guiding team can 
help mitigate this concern, however special attention needs to be afforded to explaining why task 
delegation is necessary and to frame it positively to the pharmacists (e.g., in the long-term it 
frees them up to perform clinical tasks) in order to minimize the chances of resistance (Fairhurst 
& Sarr, 1996). 
Managing the transition. Another implementation issue is related to support staff 
perceptions. Formalizing the new PT role may have a negative impact on PA morale. In the old 
workflow, PTs and PAs performed the same tasks. The new workflow would limit the scope of 
tasks that PAs can perform, and they may perceive that they have less “status” in the 
organization. To mitigate this, the guiding team needs to highlight that PAs play a critical role in 
the new workflow; that they are an integral part of the team; and that their contributions are 
essential to pharmacy functioning. This is also a key area where the proposed Structured 
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Relational Leadership approach can play a significant role. Both senior leadership and 
pharmacists need to pay careful attention to their interactions with support staff to ensure that 
both groups feel valued and included, which can improve perceived fairness (Maslyn & Uhl-
Bien, 2001). High quality leader-follow relations that empower employees and that demonstrate 
genuine empathy can go a long way in mitigating some of the anxiety that the new work 
structures may cause (Bauer & Erdogan, 2015; Mahsud et al., 2010).  
Maintaining momentum. Given that the actual launch of the new workflow isn’t 
expected to take place for at least twelve months, it is important for the guiding team to ensure 
that momentum is maintained and that the plan stays on track. Setting a hard launch date, 
consulting stakeholders, and the training that employees will be required to complete will help to 
ensure that team members remain engaged throughout the change process. Frequent and 
effective communication, which will be addressed later in the chapter, will also play a critical 
role maintaining momentum and keeping employees galvanized (Klein, 1996). The fact that the 
new workflow requires physical changes in pharmacy layout and IT system modifications will 
help institutionalize the change, making it difficult to revert to the old way of doing things. 
Limitations 
The proposed implementation plan poses several limitations that I, as CHRO, need to be 
mindful of throughout the initiative. One of the major concerns, which also extends to the 
monitoring and evaluation strategy and the communication plan, relates to implementing the two 
proposed solutions concurrently. A concurrent approach is required in order for the change plan 
to address the main factors implicated in the problem of practice. The analysis of the proposed 
solutions that was conducted in chapter two revealed that no single solution can adequately 
address all these issues simultaneously, making it necessary to implement two separate, albeit 
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complementary solutions. I explored the option of implementing the solutions consecutively, 
however, due to the inter-related nature of the solutions, that was not deemed to be an ideal 
approach. For instance, modifying the pharmacy’s workflow is directly related staff roles, 
making it necessary for the patient education initiative to incorporate those changes. Similarly, 
the redesigned workflow will allow pharmacists to dedicate more time to the delivery of clinical 
services, which also necessitates the deployment of a plan focused on educating patients on the 
services available to them.  
The main issue that arises from the concurrent implementation is over-extending the 
organization’s resources and the ability to manage both initiatives successfully at the same time. 
As highlighted earlier, each solution proposes the formation of a dedicated guiding coalition that 
is comprised of senior leadership and representatives from the pharmacist and support staff 
cadres. While it is possible, in fact recommended, that the staff representatives be different for 
each team, the Chief Pharmacist and CHRO are by default required to be part of the team 
guiding each solution. This runs the risk of senior leadership not being able to devote enough 
time or effort to either initiative, which can have detrimental effects on the outcomes of the plan. 
Being mindful of this risk, I attempted to at least partially mitigate it through the careful planning 
and scheduling of the steps for both solutions as they are being implemented.  
The presence of senior leadership in both teams, however, has its benefits, which will be 
elaborated on in the sections that follow. It allows them to monitor progress, and to shift 
resources as required in order to maintain momentum and ensure that adequate progress is being 
made. Having different staff representatives on each of the guiding teams is also beneficial for 
several reasons. First, by involving more organizational members in the change effort, employee 
engagement and buy-in can be enhanced. Second, communication between staff members 
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regarding the implementation of the two solutions can elicit unique insights that senior 
leadership may not be able to gain independently. The cross-pollination of ideas and discussions 
around the progress that is being made can also reveal issues or concerns (e.g., employee 
resistance) which allows the guiding team to address them proactively and in a timely manner.  
Another concern or possible limitation of the proposed approach has to do with the scope 
of change and the relatively compressed timeframe over which it is being implemented. At first 
glance, the scope of change may seem extensive. A careful consideration of the outcomes of 
change, however, reveals that it is in fact targeted towards addressing the symptoms of the 
problem of practice. Workflow changes cannot be implemented sequentially, as such, staggering 
the implementation of the plan over several phases is not possible due to resource dependencies 
and the sequential nature of the tasks performed in a workflow (Angelo & Ferreri, 2005). 
Additionally, the amount of time that is being dedicated to each plan is based on estimates of 
similar initiatives that had been completed in previous years (ParentCorp, 2010). That said, given 
that the launch date of the new workflow won’t be set until after all the preparations have been 
completed (mid-term goal), through the careful monitoring of progress, that date can be adjusted 
to account for unforeseen delays or additional changes that may need to be made to the plan.  
A final limitation that I need to be cognizant of is that throughout the change initiative 
and all its steps, regular pharmacy functions cannot be disrupted. Pharmacy operations must 
continue as normal in order for the organization to maintain its obligations to both patients and 
ParentCorp. This necessitates a careful consideration of how resources in the pharmacy are being 
utilized (e.g., pharmacy staff time), and can require that some activities take place outside regular 
work hours (e.g., changing physical layout of pharmacy, installation of IT terminal). As such 
additional costs may be incurred such as overtime for employees who are involved in the change 
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initiative, that are difficult to determine early on. This concern is specific to the workflow 
redesign, because the majority of the changes that are being implemented are not “patient-
facing”. In other words, a seamless transition between the old workflow and the new one once it 
is launched is essential to ensure that patients are properly served and that their healthcare needs 
are being met effectively without interruption.  
Being aware of the limitations surrounding the implementation of the change plan brings 
to the fore the importance of monitoring the progress of the implementation as well as evaluating 
the change initiative once it is rolled out. Being able to assess outcomes is extremely important, 
but so is monitoring change as it unfolds because it enables the guiding team to introduce course 
corrections should unforeseen circumstances arise. As such, designing a robust monitoring and 
evaluation strategy is an integral part of the OIP and will be discussed next. 
Change Process Monitoring and Evaluation 
Kotter’s (2012) change framework, as described in chapter two, provides for a detailed 
blueprint for organizational change. It is however lacking into key areas that are integral to the 
success of any OIP, analysis and evaluation. Chapter two addressed the organizational analysis 
aspect by utilizing Nadler and Tushman’s (1980) Congruence Model to identify areas of the 
organization where misalignment and lack of fit have contributed to the problem of practice. 
However, implementing a comprehensive change plan that combines workflow redesign with a 
public education initiative, also requires a systematic approach that explicitly incorporates 
progress monitoring and evaluation into the change process.  
Plan, Do, Study, Act  
Deming’s (1994) Plan-Do-Study-Act (PDSA) cycle for change represents a cyclical 
staged approach that can be used at a macro level to visualize and organize the change process. 
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The PDSA cycle is an iterative process-based model that is used extensively in healthcare quality 
improvement (Varkey, Reller, & Resar, 2007) and in many other industries and organizational 
contexts (Moen & Norman, 2010). At a high level, during the “plan” stage, all the aspects of the 
change initiative (who, what, where, and when) are identified, and the steps of the change plan 
are clearly put forth. During this phase, the resources that are required are also identified and a 
strategy for data collection for the purposes of monitoring progress and evaluating the outcomes 
of change is also outlined (Langley, et al., 2009). Once the planning has been completed, the 
implementation of change (i.e., the “do stage”) begins. It is during this stage that data for 
monitoring and evaluation is collected. During the “study” phase, analysing the progress and 
outcomes of change takes place to ensure that the plan is unfolding as expected. Based on the 
findings of the “study” phase, a refinement and modification of the change process, if necessary, 
is incorporated into the change plan and a new PDSA cycle starts allowing for further 
enhancement and ensuring the continuous improvement of the change process (Deming, 1994; 
Moen & Norman, 2010).  
Langley, Nolan, and Nolan (1994) put forth three questions that made the emphasis on 
monitoring and evaluating change more explicit within the PDSA cycle: “What are we trying to 
accomplish? How will we know that a change is an improvement? What change can we make 
that will result in improvement?” (Langley et al., 1994; Moen & Norman, 2010). By considering 
these questions we can determines apriori how progress will be assessed (Donnelly & Kirk, 
2015; Leis & Shojania, 2016). Table 8 below addresses these questions as they relate to each of 
the two proposed solutions.  
 
 




PDSA Cycle Change Improvement Questions 
Question Solution 1 Solution 2 
What are we 
trying to 
accomplish? 
• Improve patient 
perceptions of pharmacy 
staff 
• Improve patient 
satisfaction 
• Reduce safety incidents 
• Improve morale and 
engagement  
 
• Reduce suboptimization due to 
role overlap 
• Improve pharmacy performance 
• Reduce dispensing errors 
• Improve employee engagement 
and morale 
How will we 
know that a 
change is an 
improvement? 
Data collected: 
• Patient satisfaction 
surveys 
• Employee engagement 
surveys 
• Metrics on safety 
incidents (number of 




• Average time to fill Rx 
• Employee engagement surveys 
• Dispensing error rates 
What change 
can we make 
that will result in 
improvement? 
Based on analysis of collected data, 
changes to the education initiative 
can be introduced and modifications 
made. 
Based on analysis of collected data, further 
enhancement on new workflow can be 
made. 
 
As can be noted in the table, the answers to the question “what are we trying to 
accomplish” clearly map onto the dimensions of the problem of practice that the two solutions 
aim to address; in other words, closing the gap between the current and future states that exists in 
the organization (Langley et al., 2009). The responses to the second question set out the various 
key performance indicators (KPIs) and metrics that can be used to determine whether change has 
been successful. These will be further elaborated in the following section.  
Monitoring and Evaluation Strategy 
Traditionally, monitoring has been described as occurring during implementation while 
evaluation is conducted post-change and focuses on analysing the outcomes (Neumann, Robson, 
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& Sloan, 2018). This temporal distinction between the two functions can be somewhat 
misleading as it de-emphasizes the fact that monitoring and evaluation are results-based and 
ultimately focus on accountability and performance (Park, 2017). Moreover, by limiting 
evaluation to the end of a change initiative, leaders may not be realizing the benefits of ongoing 
feedback and may be missing out on important opportunities to further improve the change plan. 
Bunker (1978) clearly articulated that “the potential value of evaluation is realized … only when 
one treats it as an ongoing feedback component of the change process. … In this way, evaluation 
is used to generate data to help keep the program on target” (as cited in Jones & Rothwell, 2017). 
As such, for the purposes of the OIP, I will use monitoring and evaluation interchangeably, and 
will instead take a multiphase approach in developing a comprehensive strategy (Park, 2017). To 
ensure that monitoring and evaluation are properly integrated in the OIP, these critical steps 
should be done pre-intervention, during implementation (intra-implementation) and post-
intervention (Park, 2017). Pre-intervention evaluation was covered through the critical 
organizational analysis that was performed in chapter two, and the results of that evaluation were 
used to set the objectives for the OIP.  
Intra-implementation monitoring and evaluation. As a change initiative unfolds 
within an organization, it is essential that ongoing observation of progress takes place so that 
modifications to the plan can be made to mitigate challenges as they arise (Bolman & Deal, 
2013; Neumann et al., 2018). This is especially critical in my organization where two solutions 
are being implemented concurrently. For both solutions, monitoring the progress of 
implementing the change plan will be led by the guiding coalitions. During weekly meetings, 
members of each team will produce progress reports to document whether tasks specific to each 
stage have been completed. Conducting regular meetings in short intervals has been 
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recommended by scholars as it allows for feedback to be continuously collected and assessed 
(Cummings & Worley, 2008). Weekly meetings will also allow the guiding team to discuss 
future milestones and deliverables, and to assess how the change initiative is being received 
throughout the organization. These weekly meetings will enable the representatives of each 
employee group (pharmacists, PTs, and PAs) to engage with senior leadership and report any 
concerns that employees may have. This type of stakeholder engagement throughout 
implementation can help identify and mitigate resistance or opposition to change which is a 
major concern for any OIP (Carnall, 1986; Ford, Ford, & D’Amelio, 2008; Peltokorpi, Alho, 
Kujala, Aitamurto, & Parvinen, 2008). In addition to weekly meetings, senior leadership will 
hold monthly organization-wide meetings to update all employees on the status of the change 
initiatives. These meetings will also act as a forum for soliciting feedback and input, which is in 
line with the Structured Relational Leadership approach advocated by this OIP. By directly 
engaging with all employees, senior leadership can demonstrate transparency and openness, 
which can enhance trust, employee engagement, and promote buy-in (Bauer & Erdogan, 2015; 
Cawsey et al., 2016; Kotter, 2012). 
Post-intervention monitoring and evaluation. Once the change initiative has been 
implemented, the focus of monitoring and evaluation shifts more towards the results. In other 
words, answering the question: was change achieved? And if so, was it successful in addressing 
the gaps outlined in the OIP? (Cummings & Worley, 2008; Kaufman & Keller, 1994; Park, 
2017). Table 3 had outlined the data (i.e., metrics) that will be collected during the “do” stage of 
the PDSA cycle, which will be analysed during the “study” phase in order to both assess 
effectiveness and determine whether further changes are needed (prior to starting another PDSA 
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cycle). The strategy for monitoring and evaluation post-intervention strategy is therefore 
determined largely by the solution and its overall aims as discussed below. 
Solution one. For the first solution, launching a patient education/information initiative, 
requires that evaluation focus on both patient feedback as well as examining internal 
organizational outcomes. While the solution itself is not a training intervention per se, given that 
the intention is to change patient perceptions, and by extension behaviour, using components of 
Kirkpatrick’s (1998) evaluation model can provide critical insights into the effectiveness of the 
intervention (Kaufman & Keller, 1994). Table 9 below provides an overview of the four-levels 
of Kirkpatrick’s (1998) evaluation approach, as well as how they map onto the monitoring and 
evaluation strategy for this solution.  
Table 9 
Application of Kirkpatrick’s (1998) Evaluation Model to OIP’s First Solution 
 Description Solution 1 application 
Level 1  Reaction (how patients feel about 
intervention) 
 
• Patient survey on 
educational material 
• Patient survey on clinic days 
 
Level 2 Learning  
 
Not Applicable 
Level 3 Behaviour (to what extent has the 
intervention transferred over/is being 
implemented) 
• Appointments scheduled for 
clinic days 
• Number of requests for 
clinical services 
• Frequency of misidentifying 
pharmacy team members 
 
Level 4 Results (organizational benefits) • Employee engagement 
surveys 
• Number of safety incidents 
 
For the purposes of the OIP, I am interested in whether patients find the provided 
information material about the different roles of pharmacy team members as well as the 
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information regarding clinical services and the availability of clinic days useful (Level 1). As 
such, very short surveys that gauge patients’ reactions to the provided information will be 
conducted at the time that the material is delivered (i.e., prescription pickup). The results of these 
surveys will be analyzed on a monthly basis to gauge their utility and modifications will be 
incorporated as necessary. Additionally, changes in patient behaviour in two main ways will also 
be assessed (Level 3). Uptake in scheduling appointments for clinic days and requesting clinical 
services during regular visits will also be measured on a monthly basis. Analysing this data will 
allow the organization to modify the scheduling of clinic days, and allocate resources 
accordingly (e.g., additional staff members during shifts). Moreover, during clinic days, patient 
feedback will also be solicited as to whether they found the services to be useful (Level 1), and 
changes in patient behaviour when it comes to managing chronic diseases or drug compliance are 
additional indicators of intervention effectiveness (Level 3). Finally, when it comes to evaluating 
the impact of uniform changes, metrics regarding patient’s misidentifying pharmacy team 
members, and patient satisfaction surveys will also be analyzed on a monthly basis (Level 3). 
The impact of these changes on employee morale and engagement will also be evaluated on a 
quarterly basis through employee surveys. Changes in the frequency of safety incidents is a 
Level 4 organizational outcome that will be assessed every six months.  
Solution two. Modifying the pharmacy workflow is an internal change which will not be 
visible to patients. Monitoring and evaluation efforts therefore will be directed towards internal 
stakeholders (i.e., pharmacy team members) and performance metrics. As noted earlier, 
extensive stakeholder consultation will take place pre-implementation, and employee input will 
inform the changes that are enacted in the new workflow. Once the new workflow is launched, it 
is critical to gauge employee reactions on a regular basis to identify any unforeseen challenges or 
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impacts that may need to be rectified immediately (Park, 2017). As such, short employee surveys 
focusing on their reactions to the new workflow will be conducted on a weekly basis for the first 
month and on a biweekly basis during the second month. Following that, questions regarding the 
new workflow will be incorporated in the annual employee satisfaction survey. Informal 
feedback will also be solicited on a regular basis during weekly team huddles. Given that one of 
the aims of the new workflow is to address employee engagement and morale (especially support 
staff), employee engagement surveys will be conducted on a monthly basis for the first three 
months, and then on a bi-annual basis. Finally, since modifying the workflow is intended to 
address performance suboptimization, the following three metrics will be assessed on a monthly 
basis as part of the pharmacy’s regular performance evaluation: WCPS, average time to fill a 
prescription, and the number of dispensing errors.  
Plan to Communicate the Need for Change and Change Process 
One of the most vital components of a change plan that can shape the outcomes of 
initiatives within organizations is communication (Cawsey et al., 1996; Goodman & Truss, 2004; 
Kotter, 2012). A well-planned communication strategy can play a crucial role in almost every 
aspect of the change plan, from explaining the need for change and its objectives (Armenakis & 
Harris, 2002; Russ, 2008), to generating buy-in and gaining support (Kotter, 2012), and 
informing organizational members about the progress of the change initiative (Klein, 1996). A 
properly executed communication plan allows leaders to alleviate uncertainty and improve 
morale within the organization (Campbell, Carmichael, & Naidoo, 2015; Klein, 1996), while 
ineffective communication has been linked to the failure of organizational change (Coulson-
Thomas, 1997). It is therefore no surprise that communicating organizational change has been a 
widely researched topic with a vast body of academic literature and scholarly research (cf. Lewis 
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& Seibold, 1998). In this section, I outline the communication plan and strategy that will be used 
in the implementation of my OIP.  
One of the key factors that I considered in formulating the communication plan is its 
compatibility with both the change framework and the leadership approach employed in this 
OIP. Additionally, for communication to be effective, leaders should not only focus on the 
strategies and methods for communication, but also on the content of the message as that is what 
“both conveys the nature of change and shapes the sentiments that determine reactions to the 
change” (Armenakis & Harris, 2002, p. 169). Accordingly, I will use the five key change 
message components proposed by Armenakis and Harris (2002) to formulate consistent and 
accurate messaging. I will then employ Klein’s (1996) communication strategy framework as the 
blueprint for the communication plan for this OIP. 
Communication Content 
In order for a communications plan to be effective, leaders need to ensure that they 
deliver effective, consistent and clear messaging to stakeholders throughout the change initiative. 
Scholars emphasize the importance of the change message and its content, highlighting that it 
serves to coordinate the phases of change “by providing the organizing framework for creating 
readiness and the motivation to adopt and institutionalize change” (Armenakis & Harris, 2002, p. 
169). Armenakis, Harris, and Field (1999) identified five distinct and key focuses that the change 
message should be framed around: discrepancy, efficacy, appropriateness of change, principal 
support and personal valence.  
Discrepancy. Discrepancy has to do with demonstrating the need for change by 
highlighting the gap that exists between the organization’s current state and the desired state. In 
my organization, this would involve conveying to stakeholders how the organization’s current 
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performance falls short from expected standards. Senior leadership can rely on past metrics of 
employee engagement and patient satisfaction, as well as dispensing error rates and safety 
incidents to emphasize why change is needed. In highlighting these gaps and concerns as well as 
the risks involved in maintaining the status quo, leaders not only explain the need for change, but 
if done effectively, communication can ignite a sense of urgency (Kotter, 2012).  
Efficacy. It is not enough to highlight that something is wrong in the organization in 
order to gain stakeholder buy-in. When communicating the need for change, leaders should seek 
to assure stakeholders that the organization possesses the resources and the means to successfully 
implement change; in other words, leaders need to project confidence in the ability of the 
organization to succeed. Efficacy is directly linked to stakeholder motivation (Bandura, 1986), 
which is a critical ingredient in galvanizing organizational members around the change effort and 
generating momentum (Kotter, 2012). In my organization, this would be reflected in leaders 
clearly communicating the organization’s commitment to change, and the dedication of the 
necessary resources (e.g., financial, personnel, etc.) for the proposed plan. 
Appropriateness of change. Once the need for change has been established, it is critical 
that leaders explain and gain support for their vision and plan for change. Organizational 
members may agree that change is needed, but they may disagree with the specific solutions that 
are being proposed. Communicating the rationale behind the chosen solutions is therefore central 
to generating buy-in and gaining support (Kotter, 2012). In order to garner support, senior 
leadership will present the findings of the critical organizational analysis to stakeholders, as well 
as the benefits and drawbacks of the various possible solutions to addressing the gaps in the 
organization. Specifics regarding the communication strategy will be provided in the section that 
follows, but by clearly articulating the reasoning behind the choices that have been made, leaders 
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can address stakeholder concerns as well as link the diagnosis (e.g., increased safety incidents 
and performance suboptimization) with the proposed solutions (e.g., redesigning old workflow 
and educating patients) (Armenakis & Harris, 2002). In doing so, leaders demonstrate that the 
selected course of action was the result of a rigorous analytical process, not personal preference.  
Principal support. As highlighted earlier, leaders need to demonstrate that they are 
willing to commit the necessary resources for change in order to motivate employees and 
generate a sense of efficacy within the organization (Armenakis & Harris, 2002). Beyond 
pledging resources, organizational members need to be assured that senior leaders are committed 
to the change plan and its success. By being an integral part of the guiding coalitions for both 
solutions, both the Chief Pharmacist and CHRO demonstrate their direct involvement and 
personal investment in the implementation process and their support for the change effort. 
Having representatives from all employee cadres (pharmacists, PTs, PAs) reflects a willingness 
and desire for senior leadership to not just be inclusive in the decision-making process, but also a 
commitment to ensuring that the support of all key stakeholders will be sought as it is integral to 
the success of the change plan. 
Valence. This component of the communication message answers the question “what’s in 
it for me?” (Armenakis & Harris, 2002). By explaining how the proposed changes will benefit 
stakeholders personally, leaders can rally support and win over skeptical employees who may be 
resistant to change because they believe it threatens their self-interest (Armenakis & Bedeian, 
1999). In the organization, this would involve senior leadership personalizing communication for 
each group of employees (pharmacists, PTs, and PAs), and explaining how the expected 
outcomes will benefit them. For example, by highlighting how the new workflow would allow 
PTs to perform tasks autonomously, or by emphasizing to pharmacists how task delegation 
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would allow them to dedicate more time to attend to patients’ needs, those employees are more 
likely to support the change initiative. Framing the proposed changes in a personally meaningful 
way has been shown to be effective at improving support and increasing employee commitment 
to change (Kitchen & Daly, 2002; Klein, 1996). 
Communication Strategy 
While focusing on communication content is essential during organizational change, the 
best-crafted messages can fall flat if they are not communicated effectively. Quite often, 
organizational change initiatives falter because of the uncertainty they engender within 
organizational members, generating anxiety which if not addressed can lead to resistance (Jick, 
1993; Klein, 1996). As such, equally important to messaging content is the development of a 
sound communication strategy. Klein (1996) proposed six principles that form the foundation of 
a comprehensive communication strategy which will be employed in my OIP. Tables 10 and 11 
below describe the application of Klein’s (1996) principles during the OIP’s implementation, and 














OIP Communication Strategy Examples 
Communication Principle (Klein, 1996) Application 
Message and media redundancy • Townhalls 
• Memo posting on staff bulleting board 
• Use of communication binder  
 
Face-to-face communication • Townhalls 
• Use of daily team huddles 
• Biweekly staff meetings 
 
Line of hierarchy as official communication 
channel 
• Townhalls 
• Senior leadership attending staff 
meetings 
• Memos & communication authored by 
senior leadership 
 
Direct supervisor as source of communication • Pharmacist (supervisor) as 
communication vector (formal and 
informal) during team shifts 
 
Use of opinion leaders • Opinion leaders as representatives on 
guiding coalitions 
 
Use of personally relevant information (as 
opposed to abstract, unfamiliar or general 
information) 
• Employee-specific communication 
(separate communication for 
















OIP Communication Plan Timeline and Details 
Source of 
Communication 
Timeline Key Message Communication Strategy 
Senior Leadership 0 months Share the vision for 
change – why is 
change needed?  
Present organizational 
analysis results; 
highlight gaps.  
Present change plan 
(overview) 
1. Townhall led by Chief 
Pharmacist & CHRO 












1 to 4 months Regular progress 
updates on both 
solutions 
Share key milestones 
(e.g., completion of 
staff training; acquiring 
new uniforms) 
Present findings of 
workflow analysis and 
new proposed 
workflow to initiate 
consultations 
1. Team huddles 
2. Biweekly organization-
wide meetings 
3. Formal and informal 
communication through 
supervisors 















1. Townhall led by Chief 
Pharmacist & CHRO 




3. Memos included in 
communication binder 
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Table 11 (continued). 







6-10 months Regular progress 
update on 2nd solution 
Provide updates on 





Share key milestones 
(e.g., completion of 
staff training; new 
SOPs; installation of 
new IT terminal; 
physical layout 
changes) 
Present findings of 
workflow analysis and 
new proposed 
workflow to initiate 
consultations 
1. Team huddles 
2. Biweekly organization-
wide meetings 
3. Formal and informal 
communication through 
supervisors 














1. Townhall led by Chief 
Pharmacist & CHRO 




3. Memos included in 
communication binder 
12 months – Solution 2 Launched (New Pharmacy Workflow) 
Senior Leadership 
Supervisors 
12 months & 
beyond 
Regular updates on 
results of both 
solutions 
1. Team huddles 
2. Monthly organization-
wide meetings 




While Tables 10 and 11 provide a high-level framework of the details pertaining to the 
implementation of the communications strategy, it is important to highlight the specifics of the 
plan and the roles that different organizational members will play throughout the change 
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initiative in order to provide a clearer understanding of the communications plan, which is 
provided next. 
Redundancy of message and medium. Message repetition and the use of multiple 
media to deliver communication is linked to content retention (Dansereau & Markham, 1987; 
Petty & Cacioppo, 1986). Within the organization, and at every stage of implementation, 
communication will take place via multiple channels. Team huddles will be used to provide 
regular weekly updates and communications related to the change initiative. The same messages 
will also be posted in a written format on team bulletin boards and included in the 
communication binders that pharmacy team members consult at the beginning of each shift. 
Given that pharmacy work is divided in day and evening shifts, delivering communication via 
these different media will ensure that information is properly promulgated throughout the 
organization. 
Face-to-face communication. Research has consistently shown that face-to-face 
communication is more effective than any other method (Jiang et al., 2012). This is due in part to 
the interactive nature of communication and the ability of the message recipient to ask questions 
and seek clarifications as required (Gioia & Sims, 1986; Jiang et al., 2012). Prior to the 
implementation of either solution, a townhall meeting will be held with all organizational 
employees to announce the forthcoming changes and share the new vision for the organization. 
During this meeting, senior leadership (Chief Pharmacist and CHRO) will present the results of 
the organizational analysis and explain why change is urgently needed. The presentation will 
also include an overview of the change plan, the timeline for implementation, and will set the 
expectations for employees in terms of the training they will be required to complete. By 
ensuring transparency and communicating openly, as well as providing clear directions, leaders 
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will be embodying the core principles of Structured Relational Leadership, building trust and 
paving a pathway towards change. Throughout the implementation of the change initiative, 
representatives from the guiding teams will use the team huddles on a weekly basis as a means to 
communicate with team members as well as solicit their input and feedback. Additionally, senior 
leadership will conduct regular biweekly meetings with organizational members to provide 
official status updates. One month prior to the launch of each solution, additional townhalls will 
take place during which implementation specifics will be reinforced. These meetings will allow 
organizational members to ask questions directly and will also be used to maintain momentum. 
Line authority is an effective communications channel. Organizational members with 
positional power (Bolman & Deal, 2013) are highly effective messengers. As indicated above, at 
the beginning of the change initiative, senior leadership will hold a townhall meeting during 
which they will present the vision for change, the implementation plan, and address any 
questions that organizational members may have. Senior leadership should also be present for 
meetings at key milestones during the implementation. In addition to meetings, official 
memoranda and communications that will be posted on team bulletins and in the 
communications binders should be endorsed or signed by senior leadership because 
communication that comes directly from higher levels of the organizational hierarchy is often 
viewed as more legitimate and taken more seriously (Miller & Barbour, 2015).  
The supervisor is a key communicator. Linked to the previous principle, supervisors 
are critical communicators during the implementation of change. In addition to holding 
positional power and authority, supervisors are expected to be well-informed about changes 
within the organization as they typically interact with senior leadership more frequently than 
other members of the organization do. Given their daily and lengthy interactions with team 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 114  
 
 
members, supervisors are also best positioned to deliver and reinforce important messages. 
Within the organization, pharmacists as the leaders during each shift act as supervisors, and there 
is an expectation that they will play a key role in the communication strategy, both formally and 
informally, ensuring that important messages make their way to support staff members. 
The use of opinion leaders. Every organization has members who by virtue of their 
collegial relationships and personality emerge as informal leaders within the organization 
(Cialdini, Petty, & Cacioppo, 1981). These individuals have “a disproportionate impact on 
others’ opinions and attitudes” (Klein, 1996, p. 36) and as such, can be important vectors for 
communication during change initiatives. In the organization, every effort will be made to 
include these opinion leaders as representatives on the guiding coalitions, which will further 
enhance their ability to deliver messages effectively, while ensuring at the same time that they 
are perceived as authoritative sources delivering accurate information. Leveraging opinion 
leaders in the organization and including them on guiding coalitions will also have additional 
benefits such as generating buy-in and gaining employee support (Kotter, 2012).  
Personally relevant information is better retained. This communication principle is 
related to the concept of valence that was discussed earlier. While organizational members will 
be kept informed about the change initiative through the various strategies outlined above, it is 
also important to ensure that employees don’t get inundated with a deluge of information that 
may not be applicable to their roles. As such, throughout the change initiative, the guiding 
coalition will also ensure that information that is specific to different groups of employees (e.g., 
PTs, PAs) is highlighted and communicated separately. This is where having representation from 
all pharmacy team members on the guiding coalitions is highly beneficial, as each representative 
can act as a conduit for delivering personally relevant information. For example, given that PTs’ 
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roles will change significantly in the new workflow, the PT representative on the guiding 
coalition can ensure that all PTs are kept abreast of the impending modification to their roles 
within pharmacy teams. Similarly, pharmacist representatives on the guiding coalitions can relay 
critical information about the new expectations for pharmacists in terms of role delegation and 
participation in clinic days. This type of personalized communication can also assuage employee 
anxiety and ensure that the leadership team has clearly thought through the implications and 
consequences of change for each employee group as opposed to applying a broad-stroke 
approach to change that doesn’t take into account the differing needs and requirements of 
employees.  
Chapter Summary 
 Chapter three provided a detailed implementation plan for the two solutions proposed in 
the OIP. The change effort that is described provides for a comprehensive approach that aims to 
address the current gaps that exist in the organization. The ongoing improvement and 
enhancement of the change plan is made possible by the iterative monitoring and evaluation 
approach afforded by the PDSA cycle, as well as the careful and ongoing analysis of KPIs. The 
proposed monitoring and evaluation approach will extend beyond the implementation of the 
change plan as these metrics are integral to assessing the performance of the organization and 
will continue to be collected and analyzed regularly. Finally, the chapter provided an inclusive 
communication strategy and plan that focused on both the content of communication, making 
sure it is tailored appropriately to the organization, as well as employed Klein’s (1996) key 
principles that will ensure that communication efforts are in line with, and complement the 
change plan. Through careful implementation, continuous improvement, and effective 
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communication, it is expected that the organization can make significant strides in addressing the 
problem of practice.  
Next Steps and Future Considerations 
This OIP’s problem of practice manifests itself through an interconnected and complex 
set of symptoms at all levels of the organization and both internally and externally. At the macro-
level, the organization’s performance (e.g., safety incidents and dispensing errors) on its own is 
worthy of study and analysis. Similarly, at the meso-level, pharmacy team interactions have 
contributed to low employee engagement and morale, and the lack of proper integration of PTs 
has led to serious concerns with pharmacist task delegation. At the individual level, in addition to 
low morale, staff members face difficult choices: respond to patient demands for clinical advice 
and risk committing serious ethical and safety breaches or decline and be the recipient of patient 
complaints. While this operational landscape is certainly complex, it helps to be mindful that it is 
primarily the result of external changes imposed on the organization by regulatory bodies and the 
government. These concerns, as documented in chapter one, are not unique to my organization, 
but are endemic to all community pharmacies in Ontario, in Canada, and other countries that face 
similar changes (e.g., Bullock et al., 2016). From a practitioner perspective, this is actually a 
promising sign that academics will continue to examine the impacts of regulatory changes on 
pharmacy operations, and that the concerns raised in this OIP will continue to be the subject of 
both debate and examination (Rosenthal et al., 2012). As such, one of the actions that I need to 
maintain beyond this OIP is to monitor industry-wide trends and learn from the best practices of 
organizations facing similar challenges. 
 It is also important to highlight the unique nature of community pharmacy practice. In 
reviewing the literature in chapter one, and through the critical organizational analysis that was 
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performed in chapter two, one theme that kept emerging relates to the challenges of operating in 
both the public healthcare and private for-profit spheres. While the shift towards privatization is 
a hallmark of neoliberalism, it is undeniable that pharmacists continue to struggle with their 
professional identity and role perceptions, with many still viewing themselves as purveyors of 
products to clients (Austin et al., 2006; Perepelkin & Dobson, 2009). Similarly, the public also 
struggles with viewing themselves as patients as opposed to customers (Austin et al., 2006). 
Viewed from a systemic lens, this a reflection of the larger paradigm shift that the industry is 
undergoing in moving from a product to a patient-orientation. As with all paradigm shifts, 
change requires time to take hold, and the full scope of the impacts of change cannot be fully 
predicted.  
While this OIP attempts to take a comprehensive approach to change, it is very likely that 
future changes in legislation will happen. For example, there are currently some educational 
programs that are geared towards training PAs in Canada, which could be an indication that their 
role could become regulated in the future as well. Such a change would again alter the 
operational dynamics between pharmacy team members and will require further analysis and 
adaption on part of the organization. Scanning the environment regularly and interpreting 
changes will therefore be critical to adapting my organization’s operational strategy beyond this 
OIP (Beal, 2000; Thomas, Clark, & Gioia, 1993). It is for this same reason that participating in 
the discourses that will likely take place between industry and government is an important future 
step. As the healthcare system continues to face additional pressures, the role that community 
pharmacies play in the delivery of services will likely continue to evolve, be it through additional 
authorities that are given to pharmacists or enhanced collaboration with other healthcare 
providers. By proactively engaging with key stakeholders, community pharmacies can help 
ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE 118  
 
 
shape or inform the future direction that government decides to take. In doing so, community 
pharmacies, through their representatives in the OCP and other professional bodies, can perhaps 
mitigate serious concerns, such as the ones addressed in this OIP, as opposed to reacting to them 
after the fact. 
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